# Patent

## Title
Insect-combating preparation and method based on RNAi technology

## Abstract

The present invention relates to pesticide preparations and methods based on RNAi technology. The invention discloses target genes (fragments) useful in the control of Lepidoptera insects. Nucleic acid inhibitors or hosts expressing the nucleic acid inhibitors, based on the nucleic acid sequences of these target genes, can effectively kill Lepidoptera insects. The invention also discloses applications using the nucleic acid inhibitors or hosts expressing the nucleic acid inhibitors.

## Background
CROSS REFERENCE TO RELATED APPLICATIONS
This is a national stage application of PCT/CN2012/000333, filed on Mar. 19, 2012, which claims the priority of Chinese Application No. 201110067359.7, filed on Mar. 18, 2011. This application claims the benefit and priority of these prior applications and incorporates their disclosures be reference in their entirety.
TECHNICAL FIELD
The present invention relates to biotechnology and agriculture applications. More particularly, the present invention relates to RNAi-based target genes for the prevention of Lepidoptera pests, and describes direct applications of synthetic double stranded RNA preparations based on the target genes in the prevention of Lepidoptera pests in the fields.
BACKGROUND
Asian corn borers (Ostrinia furnacalis Guenée) are important agricultural pests in the world. They mainly damage economically important crops such as corns, sorghum, sunflowers, etc. Currently, the methods for preventing Asian corn borers still mainly rely on chemical prevention. However, chemical prevention causes enormous damages to the ecology and in the safe production of foods.
The myriad problems caused by chemical prevention forces us to search for better pest management methods. Although biological prevention can produce certain preventive effects, such effects are realized slowly and are not significant. In addition, biological prevention is more susceptible to environmental impacts and is not well accepted by the public. Transgenic plants can effectively prevent pest damages. However, after long-term cultivation of a transgenic plant, insect resistance to the pesticide effects of the transgenic crop can be induced, resulting in the increase of non-targeted pests. Furthermore, the safety of transgenic plants is still in dispute, limiting further development of such technology.
Since its discovery in 1991, the phenomenon of RNAi has seen rapid development. The studies show that using RNAi from specific gene, one can achieve directed interference of a target gene, resulting in certain physiological phenomenon to accomplish the studies of gene functions. In the meantime, such phenomenon is highly specific. That is, specific fragments of homologous genes can produce different interference in different species. Therefore, this is an ideal system for the control of pests.
Currently, there are reports of using RNAi technology to control insects. Baum et al. (2007) proved that v-ATPase has a lethal effect towards Western corn rootworm (WCR) (Diabrotica virgifera LeConte) and can be used to control WCR in the field. In the same year, Mao et al. introduced a P450 dsRNA into cotton, which can cause death of cotton bollworm (Helicoverpa armigera). Tian et al (2009) proved that death of beet armyworm (Spodoptera exigua Hübner) can be induced by feeding methods. These publications all show that RNAi technology as a new pest control method is feasible.
However, prior studies also show that RNAi based pest control still has some problems that need to be overcome, such as (1) how to discover target genes with fast, high throughput methods; (2) how to simplify the applications in field production; (3) resistance problems; (4) safety issues, etc. One would need to solve the above mentioned problems in order to use the RNAi technology to control pests. First, one would need to have sufficient and effective target genes so that a large number of target genes, in different combinations, can be used at different times to target different genes to achieve pest control, thereby avoiding the formation of resistant pests. Therefore, pest controls using RNAi technology hinges on solving two urgent problems: target gene identification and how to accomplish easy application in the fields. An object of the present invention is to solve these problems.
SUMMARY OF INVENTION
An object of the invention is to provide RNAi technology based pesticide preparations and methods of pest control.
In the first aspect of the invention, an isolated polypeptide is provided. The polypeptide is selected from the following:

    
    
        (a) a polypeptide having the amino acid sequence of any one of SEQ ID NO: 43-52;
        (b) a polypeptide derived from the polypeptide in (a), containing one or more (e.g., 1-20; preferably, 1-15; more preferably 1-10; more preferably 1-5; such as 3) amino acid substitutions, deletions or additions in the amino acid sequence of any one of SEQ ID NO: 43-52, and having the function of the polypeptide of (a).
    
    


In another aspect of the invention, an isolated polynucleotide is provided. The polynucleotide is selected from the following:

    
    
        (a) a polynucleotide encoding the polypeptide described above;
        (b) a polynucleotide complementary to the polynucleotide in (a).
    
    


In a preferred embodiment of the invention, the isolated polynucleotide is characterized in that it comprises a nucleotide sequence, wherein the nucleotide sequence is selected from the following:

    
    
        (a) a polynucleotide comprising the nucleotide sequence of any one of SEQ ID NO: 1-10, SEQ ID NO: 33-42, SEQ ID NO: 53-60, or a complementary sequence thereof;
        (b) a polynucleotide that can hybridize to the sequence defined in (a) under stringent conditions, or a complementary sequence thereof, wherein a dsRNA having at least one strand that is complementary to the polynucleotide, after being consumed by a pest, is capable of inhibiting the growth of the pest;
        (c) a polynucleotide that has a sequence identity with the sequence defined in (a) of at least 70% (preferably at least 75%, 80%, 85%, 90%, more preferably at least 95%, 96%, 97%, 98%, 99%), or a complementary sequence thereof, wherein a dsRNA having at least one strand that is complementary to the polynucleotide, after being consumed by a pest, is capable of inhibiting the growth of the pest;
        (d) a polynucleotide comprising a sequence of at least 17-21 consecutive nucleotides in the sequence defined in (a), or a complementary sequence thereof, wherein a dsRNA having at least one strand that is complementary to the polynucleotide, after being consumed by a pest, is capable of inhibiting the growth of the pest.
    
    


In another aspect of the invention, a vector is provided, wherein the vector contains one, two, or more of the above-described polynucleotides.
In another aspect of the invention, a genetically engineered host cell is provided. The host cell contains the above-described vector or its genome contains one, two, or more of the above-described polynucleotides.
In another aspect of the invention, applications of the above described polynucleotides are provided for the preparation of inhibition or silencing targets for interference molecules that can specifically interfere with pest gene expression or inhibit pest growth. The pest gene is selected from: LIM protein 1 gene, myoglobulin 3 light chain gene, chymotrypsin-like serine protease gene, chymotrypsin-like protease C1 gene, chymotrypsin-like serine proteinase C3 gene, hydroxybutyrate dehydrogenase gene, Kazal type serine proteinase inhibitor 1 gene, fatty acid binding protein 1 gene, and carboxypeptidase 4 gene.
In another aspect of the invention, nucleic acid inhibitors are provided. A nucleic acid inhibitor may be selected from:

    
    
        (a) a dsRNA, antisense nucleic acid, small interference RNA, or miRNA to inhibit or silence a target from polynucleotide of claim 2 or 3, after being consumed by a pest, is capable of inhibiting the growth of the pest or
        (b) a dsRNA, antisense nucleic acid, small interference RNA, or miRNA that uses a pest gene as an inhibition or silencing target. If a pest ingests the nucleic acid inhibitor, the growth of the pest would be inhibited. The pest gene is selected from: LIM protein 1 gene, myoglobulin 3 light chain gene, chymotrypsin-like serine protease gene, chymotrypsin-like protease C1 gene, chymotrypsin-like serine proteinase C3 gene, hydroxybutyrate dehydrogenase gene, Kazal type serine proteinase inhibitor 1 gene, fatty acid binding protein 1 gene, and carboxypeptidase 4 gene; or
        (c) a construct that can express the dsRNA, antisense nucleic acid, small interference RNA, or microRNA described in (a) or (b).
    
    


In another preferred embodiment, the nucleic acid inhibitor is a dsRNA produced by expression of the polynucleotide. If a pest ingests the dsRNA, the growth of the pest is inhibited.
In another preferred embodiment, the dsRNA has a structure as follows:




wherein
Seq′Forward is an RNA sequence, or a sequence fragment thereof, corresponding to any one of the polynucleotides described in claim 2 or 3, or contains an RNA sequence complementary to at least a portion of the polynucleotides described in claim 2 or 3;
Seq′Reverse is a sequence that is substantially complementary to Seq′Forward;
X′ is null or a spacer sequence between Seq′Forward and Seq′Reverse, and the spacer sequence is not complementary to Seq′Forward or Seq′Reverse;
∥ indicates formation of hydrogen bonds between Seq′Forward and Seq′Reverse.
In another preferred embodiment, the nucleic acid inhibitor is a construct that contains a structure as follows:

Seq′forward-X′-Seq′reverse 

wherein
Seq′Forward is any one of the polynucleotides, or a fragment thereof, described in claim 2 or 3, or a nucleic acid sequence complementary to at least a portion of the polynucleotides described in claim 2 or 3;
Seq′Reverse is a sequence that is substantially complementary to Seq′Forward;
X′ is a spacer sequence between Seq′Forward and Seq′Reverse, and the spacer sequence is not complementary to Seq′Forward or Seq′Reverse;
∥ indicates formation of hydrogen bonds between Seq′Forward and Seq′Reverse.
In another aspect of the invention, a host cell is provided. The host cell comprises the above described nucleic acid inhibitor.
In another aspect of the invention, use of the nucleic acid inhibitor or the host cell is provided, wherein the use is for the manufacture of a preparation for pest control.
In another aspect of the invention, a preparation for pest control is provided; the preparation comprises a safe and effective amount of a substance selected from the following: said nucleic acid inhibitor or said host cell; and an agriculturally acceptable carrier.
In another preferred embodiment, the preparation further comprises at least one selected from the following pesticides: chemical pesticide, paratin, Bacillus thuringiensis pesticide protein, xenorhabdus pesticide protein, photohabdus bacteria pesticide protein, Bacillus laterosporus pesticide protein, and Bacillus sphhaericus pesticide protein.
In another aspect of the invention, a method for the control of pests is provided. The method interferes with pest gene expression. The pest gene is selected from: LIM protein 1 gene, myoglobulin 3 light chain gene, chymotrypsin-like serine protease gene, chymotrypsin-like protease C1 gene, chymotrypsin-like serine proteinase C3 gene, hydroxybutyrate dehydrogenase gene, Kazal type serine proteinase inhibitor 1 gene, fatty acid binding protein 1 gene, and carboxypeptidase 4 gene.
In another preferred embodiment, the method comprises: feeding and/or spraying a pest with a nucleic acid inhibitor according to any one of claims 7-10 or a host cell according to claim 5 or 11.
In another preferred embodiment of the invention, the method comprises: expressing in a plant an interference molecule that can specifically interfere with pest gene expression. The pest gene is selected from: LIM protein 1 gene, myoglobulin 3 light chain gene, chymotrypsin-like serine protease gene, chymotrypsin-like protease C1 gene, chymotrypsin-like serine proteinase C3 gene, hydroxybutyrate dehydrogenase gene, Kazal type serine proteinase inhibitor 1 gene, fatty acid binding protein 1 gene, and carboxypeptidase 4 gene.
In another preferred embodiment, the method comprises: introducing the nucleic acid inhibitor according to any one of claims 7-10 into the plant.
In another aspect of the invention, a plant or a seed thereof is provided. The plant is transformed with an above-described polynucleotide.
In another preferred embodiment, the polynucleotide is expressed in a plant as a dsRNA.
In another preferred embodiment, the pest is selected from: an insect, mite, fungus, yeast, mold, bacteria, nematode, weed and parasite, and saprophyte.
In another preferred embodiment, the pest is an insect pest, including, but not limited to: a Lepidoptera pest, a Coleoptera pest, a Hemiptera pest, and a Diptera pest.
In another preferred embodiment, the pest is selected from Lepidoptera pests, preferably a corn borer or a cotton bollworm.
Other aspects of the invention will be apparent to one skilled in the art based on this description.



BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows schematic illustrating the synthesis of a dsRNA, wherein the internal sequence (intron) is 24 nucleotides long with a sequence of AATTACACTGTAACTTGCATGTAA (SEQ ID NO: 117).
FIG. 1 shows results of bioassays of 10 genes. CK is a blank control, which is a cultured Asian corn borer.
FIG. 3 shows results of real-time qPCR assessing the amounts of gene expression.
FIG. 4 shows electrophoresis results of purified dsRNA synthesized in bacteria. The sizes of the positive electrophoresis bands in DS12 and DS28 are 400-500 bp.
FIG. 5 shows results from insect body wall penetration experiments using a fluorescence labeled DS12 dsRNA. The panels on the right (vertically arranged) are fluorescence locations on the insect using Cy3 dye and viewed with the corresponding wavelength. A: immediately after dropping the labeled sample on surface of the insect body; B: 1-2 hours after the labeled sample has penetrated into 2-3 segments in the insect body; C: 4-5 hours after the labeled sample has penetrated into the entire insect body.
FIG. 6 shows the lethal effects of cotton bollworm target gene dsRNA on cotton bollworm.



DETAILED DESCRIPTION
The inventors of the present invention, after extensive research, found some target genes (or their fragments) that can be used to control Lepidoptera insects. Based on these target gene nucleic acid sequences, nucleic acid inhibitors or host cells that expressing these nucleic acid inhibitors can be used to effectively kill Lepidoptera insects.
DEFINITION
In this description, the term “plant” does not have any specific limitation, as long as the plant is susceptible to pest (e.g., Lepidoptera insects) infestation, such as various crops, flowering plants, or forestry plants, etc. The plants, for example, may include (but are not limited to): dicotyledonous plants, monocotyledon plants, or gymnosperm plants. More specifically, the plants may include (by are not limited to): cotton, wheat, barley, rye, rice, corn, sorghum, beet, apple, pear, plum, peach, apricot, cherry, strawberry, raspberry, blackberry, bean, hyacinth bean, pea, soybean, rape, mustard, poppy, olive, sunflower, coconut, castor oil plant, cocoa bean, peanut, gourd, cucumber, watermelon, flax, hemp, jute, orange, lemon, grapefruit, spinach, lettuce, asparagus, cabbage, Chinese cabbage, pakchoi, carrot, onion, potato, tomato, green pepper, avocado, cinnamon, camphor, tobacco, nuts, coffee, eggplant, sugar cane, tea, pepper, grape vine, oyster linen, banana, rubber plant, and decorative plants.
In this description, the term “Lepidoptera insect” refers to any Lepidoptera insect, the genome of which contains a gene (or a fragment) of any one of SEQ ID NO: 1-10. Furthermore, these genes are essential for the growth or survival of the insects. The Lepidiptera insects include moths, specific examples of which include Tineidae and Oecophoridae (such as Tneola bisselliella, common clothe moth), and Pyralidae (such as Pyralis farinalis, Meal moth), etc.
In this description, the term “RNA interference or RNAi” refers to certain RNA that can efficiently and specifically block specific gene expression in vivo, stimulating mRNA degradation, inducing the cell to have phenotypes due to loss of specific genes. It can also be referred to as RNA intervention or interference. RNA interference refers to a highly specific gene silencing mechanism at the mRNA level.
In this description, the term “interference RNA” or “dsRNA” refers to an RNA molecule, which can use a homologous complementary sequence to target an mRNA to degrade a specific mRNA. This process is referred to as an RNA interference pathway.
In this description, the term “substantially complementary” refers to nucleic acid sequences that are sufficiently complementary and can interact with each other in a predictable manner, such as forming a secondary structure (e.g., a stem-and-loop structure). Normally, two “substantially complementary” nucleotide sequences have at least 70% nucleotides that are complementary; preferably, at least 80% nucleotides that are complementary; more preferably, at least 90% nucleotides are complementary; further preferred, at least 95% nucleotide are complementary, such as 98%, 99% or 100%. Generally, two sufficiently complementary molecules can have at most 7 unmatched nucleotides between them; preferably, at most 6 unmatched nucleotides between them; more preferably, at most 5 unmatched nucleotides between them; further preferred, at most 4 unmatched nucleotides between them, such as 0, 1, 2, 3, or 4 unmatched nucleotides.
In this description, the term “complementary” sequences refer to changing the sequence form 5′→3′ direction to 3′→5′ direction (e.g., 5′ATCG 3′→GCTA), and then obtain a complementary sequence (e.g., GCTA→5′CGAT 3′).
In this description, the term “stem-and-loop” structure is also called “hair-pin” structure, which refers to a nucleic acid molecule that can form a secondary structure containing a double stranded region (stem), wherein the double stranded region is formed by two regions in the nucleic acid molecule (i.e., on the same molecule). Two regions each form one side of the double stranded region. The structure further comprises a “ring” structure, which comprises non-complementary nucleic acid molecule, i.e., single stranded region. Even if the two regions in the nucleic acid molecule are not completely complementary, the double stranded region can still maintain the double stranded condition. For example, insertion, deletion, substitution, etc. can lead to a small region that is not complementary or that small region may form a stem and loop on its own, or it forms a secondary structure in other manners. However, those two regions are still substantially complementary, and may interact with each other in a predictable manner to form a stem in a stem-and-loop structure. Stem-and-loop structures are well known to one skilled in the art. Normally, after obtaining a primary nucleic acid sequence, one skilled in the art can ascertain whether that particular nucleic acid can form a stem-and-loop structure.
In this description, the term “nucleic acid inhibitor” is a general term referring to a material prepared based on a target gene or a fragment thereof or a shortened form thereof, which is useful for controlling Lepidoptera insects according to the invention, and having an activity for controlling Lepidoptera insects. The nucleic acid inhibitors for example can be certain interference molecules, including dsRNA (also referred to as, double-stranded RNA, double-stranded ribonucleic acid, or double-stranded ribonucleic acid sequence), antisense nucleic acid, small interference RNA, micro RNA, or a construct that can form the dsRNA, antisense nucleic acid, small interference RNA, or micro RNA.
In this description, the term “operatably coupled” or “operatively coupled” refers to two or more nucleic acid regions or nucleic acid sequences are functionally arranged in space. For example, a promoter may be placed at a specific location relative to the target gene nucleic acid sequence such that the transcription of the nucleic acid is promoted by the promoter. Thus, the promoter region is said to be operatively coupled to the nucleic acid sequence.
In this description, “an RNA sequence corresponding to a DNA sequence” refers to an RNA sequence, wherein if the DNA sequence contains “AT”, then the sequence is “AU” in the RNA sequence.
“Contain,” “have,” or “include” includes “comprise,” “mainly consist of,” “consist essentially of,” and “consist of.” “mainly consist of,” “consist essentially of,” and “consist of” are species in the genus of “contain,” “have,” or “include.”
Gene
To search for target genes (or fragments thereof) useful in the control of Lepidoptera insects, the inventors carried out extensive research. After extensive research, the inventors found that the following genets are critical genes for insect development and growth and down regulation or inhibition of these gene expression can lead to growth problems or death in insects: LIM protein 1 gene, myoglobulin 3 light chain gene, chymotrypsin-like serine protease gene, chymotrypsin-like protease C1 gene, chymotrypsin-like serine proteinase C3 gene, hydroxybutyrate dehydrogenase gene, Kazal type serine proteinase inhibitor 1 gene, fatty acid binding protein 1 gene, and carboxypeptidase 4 gene.
Using the above described genes as targets for inhibition or silencing, one can prepare specific interference molecules to inhibit the growth of corn borers. This invention also provide genes from cotton bollworm that are highly homologous to the above-described genes as inhibition or silencing targets for the preparation of specific interference molecules to inhibit cotton bollworm growth. The above-described genes may also originate from other species. The functions of these genes have been documented in the literature; the nucleic acid sequences are highly homologous to those of corn borer. Therefore, it is predictable that these highly homologous genes can also be targets for the preparation of interference molecule to inhibit the growth of other species.
In this description, the term “highly homologous” or “high homology” when referring to a nucleic acid sequence, it means that the nucleic acid sequence can hybridize to corn borer genes SEQ ID NO: 43-52, or their complementary sequences, under stringent conditions. A sequence that can hybridize to corn borer genes SEQ ID NO: 43-52, or their complementary sequences, under stringent conditions, is a sequence that can form antiparallel pairing between the two sequences. Then, the two sequences can form hydrogen bonds between the bases on the opposite chains under stringent conditions to form a dimer, which is sufficiently stable under the stringent conditions and can be detected by methods known in the art. Preferably, these highly homologous sequences have sequences identities of about 65% to about 70% with any one sequences of the corn borer SEQ ID NO: 43-52, or their complementary sequences, or more preferably, about 80% to about 85% sequence identities, or more preferably, about 90% to about 95% sequence identities, to about 99% sequence identities.
Methods for confirming sequence identities are well known in the art, including using BLAST software and EMBOSS software (The European Molecular Biology Open Software Suite (2000), Rice, P. Longden, Land Bleasby, A. Trends in Genetics 16(6), pp. 276-277). In this description, the term “identity” refers to the relationship between sequences at the nucleic acid level. Two or more sequences, in the optimal alignments within a comparison window, are compared to confirm the identity percentage, wherein the portion of the sequences within the comparison window can have insertions or deletion, as compared with the optimally aligned reference sequence. The reference sequence does not include any insertion or deletion. The reference window is selected for at least 10 consecutive nucleic acids to about 50, about 100, or about 150 nucleic acids. Then, by identifying the number of nucleic acids that are identical between the sequences within the window, and divide this number by the total number of nucleic acid in the window, followed by multiplying it with 100 to calculate the identity percentages.
Among the above-described target genes, the inventors further studied target genes or their fragments that can be effectively down regulated. This leads to the identification of 10 target gene fragments, the nucleic acid sequences are selected from any one of SEQ ID NO: 1-10.
The fragments or shortened forms of the target genes (fragments) are within the scope of the invention, as long as these fragments or shortened forms can be used to prepare nucleic acid inhibitors having activities that can kill Lepidoptera insects.
The inventors unexpectedly discovered that these target gene fragments or their shortened forms play important roles in insect bodies. If they are inhibited, interfered with or silenced, it would lead to greatly reduced survival rates or directly lead to death of the insects. Therefore, one can design various nucleic acid inhibitors based on these target gene fragments in order to control pests.
This invention provides a polynucleotide set, wherein the polynucleotides comprise the sequences of SEQ ID NO: 1-10. When preparing nucleic acid inhibitors or its preparations for controlling Lepidoptera insects, one can obtain 1-10 polynucleotides from the polynucleotide set. One can based on multiple polynucleotide sequences (preferably, for example 10 sequences) to prepare nucleic acid inhibitors or host cells that express the nucleic acid inhibitors. When these sequences are used at the same time (or in combination), they can achieve broader spectrum and more effective control of Lepidoptera insects.
Nucleic Acid Inhibitors
Any material, prepared based on a target gene (fragment) or its fragment or shortened form provided in this invention and having activities for controlling Lepidoptera insects, can be nucleic acid inhibitors for use in controlling Lepidoptera insects. The nucleic acid inhibitors preferably are interference molecules, such as a dsRNA, antisense nucleic acid, small interference RNA, or micro RNA construct, or a construct that can express the dsRNA, antisense nucleic acid, small interference RNA, or micro RNA. More preferably, they are dsRNA or a construct that can express the dsRNA.
Based on the genes or their sequences provided by this invention, one can design a construct for expression of dsRNA, antisense nucleic acid, small interference RNA, or micro RNA. Therefore, the invention also provides artificial constructs. The constructs of the invention that are based on the genes or sequences disclosed in this description would be understood by one skilled in the art. Generally, the construct can include an internal sequence (not complementary to the flanking sequences on both sides) with complementary gene sequences attached to both ends of the internal sequence. After being introduced into a cell, this can form a “stem-and-loop” structure, and the “stem” portion forms dsRNA, antisense nucleic acid, small interference RNA, or micro RNA. These dsRNA, antisense nucleic acid, small interference RNA, or micro RNA can effectively inhibit the expression of the target genes.
In a preferred embodiment of the invention, the construction comprises at least one of the following structures:

SeqForward-X-SeqReverse 

Wherein the nucleic acid sequence in SeqForward is selected from any one of the sequences of fragments of SEQ ID NO: 1-10 and SeqForward and SeqReverse have substantially complementary nucleic acid sequences.
X is a spacer sequence located between SeqForward and SeqReverse, and the spacer sequence is not complementary to SeqForward or SeqReverse.
The formula I structure above can form the following secondary structure:




The structure can be further cleaved, processed to form a double-stranded interference molecule to exert its gene silencing function.
The construct may be prepared to form one or more stem-and-loop structures. For example, it can contain 2 or more than 2 stem-and-loop structures.
Normally, the constructs are on expression vectors. Therefore, the invention includes a type of vectors, which comprise the described constructs. The expression vectors normally also contain promoters, transcription origins, and/or marker genes that are operatively coupled to the constructs. Methods known to one skilled in the art may be used to construct the expression vectors of the invention. These methods include in vitro recombinant DNA technology, DNA synthesis technology, in vivo recombination technology, etc. The expression vectors preferably comprise one or more selection marker genes to confer a characteristic that can be used to selected the transformed host cells. Examples of selection markers include kanamycin, gentamicin, hygromycin, and ampicillin resistance markers.
A vector containing an above-described gene sequence and an appropriate promoter or control sequence may be used to transform an appropriate host. In accordance with methods of the invention, the host may be any host that is suitable for carrying the expression vector and also can express the nucleic acid inhibitors. For example, the hosts may be E. coli, fungi, yeasts, plant cells, animal cells, etc.
The methods for transforming a host using a recombinant DNA can be any techniques known to one skilled in the art. An actual method used may depend on the type of plants. When a host is a prokaryote, such as E. coli, competent cells that are capable of intaking DNA may be harvested after exponential growth period and the transformation may use CaCl2 treatment. The steps used in this transformation are commonly known in this field. Another method is to use MgCl2. When necessary, one may also use electroporation. Transformation methods for yeast cells, plant cells, or animal cells are also well known to one skilled in the art.
A host cell carrying an above-described construct or an expression vector may be directly used on the target of protection (e.g., plants) to achieve the control of Lepidoptera insects.
The “stem” portion of a stem-and-loop structure is formed by interaction between SeqForward and SeqReverse. The stems can be processed to produce nucleic acid inhibitors. The nucleic acid inhibitors may have the following structures:




wherein SeqForward is an RNA sequence or a fragment thereof corresponding to any one sequence of SEQ ID NO: 1-10 and SeqReverse contains a sequence that is complementary to that of SeqForward. X′ is a spacer sequence located between SeqForward and SeqReverse. The spacer sequence is not complementary to SeqForward or SeqReverse. The X′ sequence may be removed in vitro or not removed. When dsRNA enters an insect body, it may be processed and removed by an enzyme (e.g., nucleic acid enzyme, Dicer) in the insect.
The nucleic acid inhibitors may be directly used on targets needing prevention (e.g., plants) to achieve the purpose of controlling Lepidoptera insects.
Transgenic Plants
The invention relates to methods for improving pest resistance in plants. A method of the invention comprises introducing a nucleic acid inhibitor into a plant. Plant transgenic techniques are well known to one skilled in the art, such as Agrobacterium tumefaciens transformation techniques or gene gun transformation techniques, etc., and also leaf-disc method, embryo transformation methods, etc. A transformed plant cell, tissue or organ can be regrown into a plant using regular methods to produce pest resistant plants.
Preferably, a method for improving pest resistance in a plant comprises:

    
    
        (1) providing an Agrobacterium tumefaciens carrying an expression vector, the expression vector comprises an above-described nucleic acid inhibitor;
        (2) contacting a plant cell, tissue, or organ with the Agrobacterium tumefaciens of step (1) to transform the nucleic acid inhibitor into the plant cell, tissue, or organ;
        (3) selecting the plant cell, tissue, or organ that has been transformed with the nucleic acid inhibitor; and
        (4) regenerating a plant using the plant cell, tissue, or organ from step (3).
        The described method may be carried out using any appropriate regular means, including reagents, temperatures, pressure conditions.
    
    


Currently, using plants as a medium, to inhibit insect growth or kill insects by feeding insects with nucleic acid inhibitors (interference molecules) that can interfere with insect gene expression is well known to one skilled in the art. For example, Ying-Bo Mao, et al., “Silencing a cotton bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval tolerance of gossypol,” Nature Biotechnology, Vol. 25, No. 11, November 2007, proves the effectiveness of these methods.
Compositions and Methods for Controlling Lepidoptera Insects
The invention provides a preparation (e.g., a pesticide composition), which comprises a safe and effective amount of a construct, a host (cell) carrying an expression vector capable of expression nucleic acid inhibitors, or a nucleic acid inhibitor (e.g., 20-500 μg/ml); and an agriculturally acceptable carrier.
In this description, the term “comprise” refers to various components may be used in a mixture or composition of the invention. Therefore, the term “mainly consist of” and “consist of” are included in “comprise.”
In the present invention, an “agriculturally acceptable” component refers to a material that is suitable for use in agriculture and has a reasonable benefit/risk ratio without posing excessive adverse effects (e.g., toxicity, irritation, and allergic reaction) to human, animal (except Lepidoptera insects), or plants.
In the present invention, an “agriculturally acceptable carrier” is a solvent, a suspending agent, or an excipient used to deliver a construct or a host cell that carries an expression vector capable of expression a nucleic acid inhibitor, or a nucleic acid inhibitor of the invention to a Lepidoptera insect. An agriculturally acceptable carrier can be a liquid or a solid; preferably it is a carrier that can preserve the activities of the hosts or the nucleic acid inhibitors.
The preparations (or agricultural compositions) may be in various dosage forms, including (but not limited to): aqueous solution, suspension, wettable powder, emulsifiable concentrate, lotion, a spray solution, aqueous dispersion, powder, granule, or microcapsule. It should be understood that as long as it can deliver a construct or a host cell that carries an expression vector capable of expression a nucleic acid inhibitor, or a nucleic acid inhibitor of the invention to a Lepidoptera insect, while preserving all or part of the activities. Preferably, a dosage form is that which is easy to deliver. For example, an agricultural composition may be a liquid spraying agent or a nebulizing agent.
In the present invention, an adjuvant is an auxiliary component, which has an auxiliary regulation function in a composition. For example, it may be a surfactant, adhesion promoter, or other auxiliary agent.
In agricultural composition concentrates, the active ingredients (i.e., a host carrying a construct or an expression vector that can expression a nucleic acid inhibitor, or a nucleic acid inhibitor of the invention) are present at high concentrations. For example, a concentration may contain nucleic acid inhibitors at 200-500 μg/ml, and application dosage is 50-1000 μl/300-500 heads. Alternatively, based on the contents of the host carrying a construct or an expression vector that can expression a nucleic acid inhibitor, or a nucleic acid inhibitor of the invention, and with reference to the application dosage of the nucleic acid inhibitor, to apply a certain amount of the host (cell). In addition, a composition concentrate can also contain other suitable common components: chemical agent, synergistic agent, trace element, stabilizer, adhesion agent, wetting agent, dispersion agent, surface active agent, permeate agent, tanning agent, solvent, filler, etc. An agricultural composition of the invention may further comprise other active insecticides or microbicides.
In preparing an agricultural composition, a suitable solid diluent may include, but not limited to: clay, such as diatomaceous earth, corn husk, tricalcium phosphate, cork powder, kaolin, betonies, or attapulgite etc., and a water soluble polymer.
In addition, solid compositions may also include one or more compatible wetting agents, dispersion agents, surface active agents, or coloring agents. These components may also function as a diluents in solid forms.
These solid compositions may be powders, granules, or wettable powder dosages. Generally, powders are obtained by grinding, and granular forms, tablet forms or brick forms may be obtained from granules.
Liquid compositions may be in the form of solutions, suspensions or emulsions. They may be enclosed by natural or synthetic polymers, and may include wetting agents, dispersion agents or surface active agents. Such locations, suspensions or solutions may use aqueous, organic, or water-organic diluents to prepare water soluble polymer (and a mixture of the above diluents). In addition, the diluents may include, for example, ionic or non-ionic wetting agents, dispersion agents, or emulsifiers, or their mixtures.
The principles for the various preparations are known and are described, for example, in the following publications: Winnacker-Kuchler, “Chemische Technologie,” Vol. 7, C. Hauser Verlag Munich, 4th Ed., 1996; van Valkenburg, “Pesticide Formulation,” Marcel Dekker, N.Y., second edition, 1972-73; K. Martens, “Spray Drying Handbook,” the third edition, G. Goodwin, Ltd., London.
The auxiliary agents (such as inert substances, surfactants, solvents and other additives) for the preparation of compositions of the invention are known in the art and described in, for example: Watkins “Hand-book of insecticide Dust Diluents and Carriers”, 2nd, Ed., Darland Books, Caldwell N.J.; H. v. Olphen, “An Introduction to Clay Colloid Chemistry,” 2nd Edition, John Wiley & Sons, New York, 1977., Marsden, “Solvent Guide” 2nd Ed., Interscience, N.Y. 1950; McCutcheon's, “Detergents andEmulsifiers Annual”, MC Publ. Corp., Ridgewood N. J.; Sisley  Wood, “Encyclopedia of Surface Active Agents”, Chem. Publ. Co. Inc., N.Y. 1964; Schonfelt, “Grenzflachenaktive Athylenoxidaddukte,” Wiss. Verlagsgesell., Stuttgart 1976; Winnacker-Kuchler, “Chemische Technologie,” Vol. 7, C. Hauser Verlag Munich, 4th Ed., 1986.
Wettable powder can evenly distribute in water. In addition to surface active agents, wettable powders can also include wetting agents, dispersion agents, diluents, etc. that are not environmentally harmful substances. Preparation of powder formulations may comprise: grinding a surface active agent with a natural clay or diatomaceous earth solid substance such as talc, kaolin, betonies, etc. Granular formulation can be prepared by spraying active ingredient to allow it to adsorb on inert substance particles, or apply the active ingredient on the surface of a carrier (such as sand, kaolin, or inert substance granules) with aid of an adhesive agent (such as polyvinyl alcohol, sodium polyacrylate, or mineral oil). If used with a fertilizer, the active ingredient may be prepared in granules as in the preparation of fertilizer granules.
As for controlling insect attach of plants, delivering dsRNA that is for insect control to the plant surfaces by spraying application is an alternative method for protecting the plants. Under this condition, genetic engineered bacteria for producing and accumulating dsRNA may be fermented, and the fermentation products may be formulated as a spray that is compatible with commonly used agriculture application. The formulation may comprise: a colloidal agent and wetting agent for highly efficient covering of leaves, and a protective agent for protecting dsRNA from UV damages. These additives are commonly used in biocide insecticide industries, and are well known to one skilled in the art. Similarly, for application in soils, the formulations can include the following granular formulations, larvae baits for use to control soil pests (such as, corn rootworm).
Wherein the bacteria or yeast cells are killed, such as through heat treatment or mechanical treatment.
The inventors accidentally discovered that the nucleic acid inhibitors may enter the insect body by permeation. Therefore, one can use various nucleic acid inhibitors or compositions comprising various nucleic acid inhibitors to apply on insects to achieve control of the insects. The application methods can include, but are not limited to, spraying, spread, or dropping onto insect body surface. The nucleic acid inhibitors may be selected from: dsRNA, antisense RNA, small interference RNA, micro RNA; or a construct capable of expressing the dsRNA, antisense RNA, small interference RNA, micro RNA.
This invention provides a method for the control of Lepidoptera insects. The method comprises: applying a host carrying a construct or expression vector for expressing a nucleic acid inhibitor or the nucleic acid inhibitor on to the target (e.g., plants, especially, plants that are susceptible to Lepidoptera insects; or insect itself).
In addition, it is also possible to directly use the nucleic acid inhibitors, an agricultural composition comprising the nucleic acid inhibitors, or a host capable of expressing the nucleic acid inhibitors to feed insects or to spray insects. The agricultural compositions may be prepared as a spray formulation for direct spraying to control pests.
This invention addresses the problems in Lepidoptera insect controls. Based on RNAi technology, 10 fragments of target genes that can be used in field prevention and control have been developed. It is proven that inhibiting gene expression by nucleic acid inhibitors, using a simple method of spraying, is effective, leading to death of Lepidoptera insects, thereby achieving the control purpose. The methods are convenient, fast, accurate, and do not cause any pollution.
Advantages of the Invention Include
(1) This invention discloses 10 target genes for the control of Lepidoptera insects for the first time, and proves that nucleic acid inhibitors based on these target genes can be directly applied in pest control. The pest control methods are convenient, fast, accurate, and can solved the problems faced by currently pest control: resistance and environmental incompatibility.
(2) RNAi technology is a new pest control technique that is efficient, specific control, and non-polluting. The dsRNA obtained can be directly applied in the field for pest control.
(3) There are a large number of target genes for screening. By random replacement of the target genes or mixed use of the target genes, it is possible to avoid occurrence of resistance in the target pests.
(4) It is possible to select target genes specific for a particular species, thereby minimizing the impact on non-target.
(5) the R&D costs are low, and can be rapidly move to production.
(6) The methods are convenient and have good environmental compatibility.
In the following, the invention will be further explained using examples. It should be understood that these examples are for illustration of the invention and are not intended to limit the scope of the invention. In the following experimental methods, the conditions not specified are as those commonly used in the art, such as those described in Sambrook et al., Molecular Cloning: A Laboratory Guide, (New York: Cold Spring Harbor Laboratory Press), or those suggested by the manufacturers.
Unless specifically defined, the scientific terms and terms in the art are used as understood by those skilled in the art. In addition, any methods or materials that are equivalent to those described herein may also be used in this invention. The preferred examples of methods and materials described here are for illustration only.
Example 1: Cloning of a Full Length Target Gene from Corn Borer and Target Gene Fragments Information
The inventors screened and selected 10 target genes from a large number of genes (Wang et al., PLoS ONE, 6(4):e18644; and Chinese Invention Patent 201010197328.9). The sequences and inform of these gene fragments are shown in TABLE 1. The temporary names of the proteins encoded by these genes are shown in TABLE 2.









TABLE 1






SEQ




ID



Name
NO:
Sequence







DS2
 1
TATCTTCGCCCTGTACTGTAATACGCGTTCGGGAGCTCGACTCTCGTAGCGACTCGACGAACAGGATAA




GTTAAGCGAGCACAATGCCTTTCAAACCAGCAGACAACCCCAAGTGTCCGAAATGCGGCAAGTCCGTAT




ACGCAGCCGAGGAGAGAGTAGCCGGTGGACTGAAGTGGCACAAGATGTGCTTCAAGTGCGGACTGTGC




CAGAAGTTGCTGGACTCCACCAACTGCTCAGAACACGAAGGTGAACTGTTCTGCAAAGTATGCCACGC




GCGCAAGTTCGGTCCCAAGGGCTACGGCTTCGGCGGTGGCGCTGGCTGCCTTTCCATGGACGCTGGTG




AACACCTGAAGGCTGAAGATGCGAATTGAGCGCGAGCAGCCATCCAGCAGAGCTAGCGGGTCGCTC




TCCCTATAGTGGGTTCGTAAATAAA


 


DS3
 2
CCATCCATGTTCTCACAGAAGCAGGTCGCCGAATTCAAGGAGGCCTTCCAGCTAATGGA




CCACGACAAGGACGGTATCATCGGCAAGAACGACCTCCGCGCCACCTTCGACTCGCTCGGC




AGGCTGGCGTCCGAGAAGGAGCTGGACGAGATGGTGAACGAGGCCCCCGGCCCCATCA




ACTTCACGCAGCTGCTGACCCTCTTCGCCAACCGCATGTCCGGCGGCTCCGACGAGGACGA




CGTCGTCATCAACGCCTTCAAGACCTTCGACGAGGAGGGCAAGATCGACTCCGAGAGGCT




CAGGCACGCGCTCATGACCTGGGGAGACAAGTTCTCCGCCGACGAGGTCGACGAGGCCTA




CGACCAGATGGAAATCGACGACAAGGGCTTCATCGACACCACCAAGCTCATCACCATGCTG




ACCGCCGCCGCTGAGGAGGACGAGGGCGGCGAAGCTGCGTAGTTCCACCCGCGCCAGT




CTCCCTATAGTAG


 


DS5
 3
TGCGGCAGTTCGCTGGTCAGCAACACGCGCTCGGTGACGGCGGCTCACTGCTGGCGCACCAGCACC




TTGCAGGCGACCATGTTCACCATCGTGTGGAACTCTAACTCTATATTCTGGGGCGGCACGCGCATA




AACACCAACCAGGTCATAGAGCACCCGAATTACAACGTGTGGAACTTGAACAACGATGTGGCCGT




CATCATACACAACCACGTAAATTTCAACAATAATATCCAGCCAATTGCCCTGGCCACTGGCTCGC




AAACCTACGCGGGAACCTGGGCAGTCGCTGCTGGATACGGCCAGACTGGCGATGGTAATTCACCG




TCTGGCACTAAGTTCCAAGCCAATCTGCTGGTGATCACCAACTCAGCGTGCCAGGGAACCTGGATG




CCCGGCATCGTCATCGCGTCCA


 


DS6
 4
GTCAGAGTCAGGGCTGGCGGTCCCATCTCCGCTCAGCTCCTCGAGTTGACCGTGACCACCATCTCT




GGCGATCAGTGCGTGCGCGACGTGGCCCAGGCCTCCGTCGACTTCAACGTCGCCGCCCCACCGGTG




GAACCCCACGTCGAGCTCTGCATCATCCACTCGCCGAACCACGGCATGTGCAACGGTGACTCCGGC




AGCGCTCTAGTCCGCCTGGACCGCGGCACCCAGATCGGAATCGTGTCGTGGGGCTTCCCCTGCGCC




CGCGGCGCTCCCGATATGTTCGTCCGAGTCAGCGCCTTCCAAGACTGGGTCGCCCGCCACTTCGTT




GCTTGTCTCCCTATAGTGAGTCGTATTAA


 


DS10
 5
ACCGGGTCGTGCTCGGCTCCACACTATCTTCAGCGGTGGTGTCCGTCAAACCACCTCTGACATTGTC




ATGCACCCACAGTGGACCCCGGAGACCGTTGCTAATGACATTGCCGTCATTAGGATTAACGCTGTTAC




TTTCACCAATGTGATCCAGCCCATCTCTCTGCCCAGCGGATCTCAGCTAAATAACAACTTCGTAGGCC




AGGTCGGAATTGCTTCTGGATTCGGACGCACTTCTGATGGTGCTAACATCCCGAACAACCAACTC




GTGAGCTGGGTGAGAGTGCCGATCATCACCAACCAGGCGTGCGCCTCAGTCTTCGGACCCTTCAT




CTTAAGTAGCACCATCTGCACCAACGGCTCTGGTGGTATGGGCACGTGCCAGGGAGACTCTGGTG




GTCCTCTCGCTGTGGAAGTTGGCAACTCTAGGGTCTTGGTTGGTGTGACTTCCTTTGGTGCTGCTGC




CGGTCTCCCTATAGTGAGTCCGTAATAAA


 


DS12
 6
TTGCCATCGTTGGAGAACGCAGCCAAACTAAAAGATGTTACGGAAAGTATCTCGAAGGTCGGTA




ACAAGCCTCTTGTGATCACCGCCGATGTTACCAAAGAAAGTGATGCTCAAAGAATCATCAACGA




TACAGTAAAACATTTTGGAAAACTTGACATTCTTGTCAACAATGCAGGAGTGGGTGGCAATGCC




AGCATTACTGAAGCAGAAGCCATGACAACATTTGACCATATCATGAATACCAACCTGCGTTC




CGCTGTCTACATGACCAATCTGGCTGCCAAGCATCTTATTGAAACGAAAGGGAATGTAATAAA




CATATCAAGCGTTGCTGGTCAAATGGTGATGGAAAAAGGGTTTGCTTACTGCACCTCAAAA




GCTGCCTTGGATCATTTCGCGAGATCAATCACGTTGGACTTTGCGCCACATGGTGTTCGCGTGA




ACAACATTAGCCCTGGGCCGGTGAGGTCTCCCTATAGTAGTCGTATTAA


 


DS28
 7
AAGAACCATGCCGATCAGCTGATCAGTGCCCACGTCCAGCAGTGGGAACCACGGCAGGAGGGT




GTCAGACCTGCACTCGGTGGCGGTTGTCATGTTGTAGTAGTAGTGGCGACCCATGAGAATAAT




GCAAGCTTGTTTGGTGAAATGGGTGGTGGCGGTGTCGGTGACCTCGTTGGCGTTGCCGGAGA




TCCTCATCAGGTCTCCGTTGAAGCCGGTGACCCACACAGCATTCTCCTGCAGTACGCGGCCTGC




CACGCGGGAGGCGCGGCGCTCCTCCTTGCTCTTCTTCAATGTGGCTTCAGAAACGAAGTAT




TGCTGCAAGGTCCAGTAATTCCTAACTTGTCCATTAGAGTTTGCCGGTGCAGTCCAGTACGTG




TAGCCTTGGGTAGCCCAGTCCAAGACAGCGCCGTCTCCCTATAGTGAGTCGTATTAA


 


DS30
 8
CCGCGCAGCGTCGCCCCGCGTCCTACTTTACTAAACTTGGAAGGTGCAAACAGTTCATCTAC




GGAGGATGTGACGGCAACGGCAACCGTTACAACACTCTAGAGGAGTGTCAGGCTGCTTG




CGAGAGTGACTGCAACAAATAATAACGAAATGCAAGCAATCAATTGGGTATTTGACAGC




ACAGTCAATTGACATACTTTTTTTATACTGTCAAAACGCACCATTCCCTATTTTTCACATT




TTGCAAAGTAGAGGGAATCTAAAGGCCATAGCAGACTTATCAACTCGGAAAGGGATCA




TACCGTATCGCCGTTCGCGAGCTATCATCGCCTTTCGCGCGCTGTCAACTGTCAACCGCGA




GGCGAGGCGTTTACGTTACTGTGCGGATAAGTGTGGGTTACAGTATGGAATTTCACACTGA




TCGCATCAATTTAATACGGTTACAATCCCTGTCCGGGTTGAAAAGTGGGCCCTCCCAAT




AGGGAGCCGAATAAA


 


DS34
 9
GGGCCTTCATGCAGTACAAGCCGAACCAGATCCTCGAGAAGAACGGGGACTCCTACAAGCTGA




TCTTCAAGACCCCCGCCCTGAACCACGAGGTGGTGTTCAAGTCTGGAGTGCCTTACA




GCGACGTCATCCGTGAAGGTTTGACGGCTGAATCCACCATCACCGTCGATGGAGACACC




TTCACTCAGGTCCAGGACTACGGCCCCCTTGGCTCCATCACCTTCAAGAGAGAGTACAGCG




CCGACCAACTTAAAGTGACTGTCACCAGCAGTAAATGGGATGGCGTTGCCTACAGATCTCC




CTATAGTGAGTCGTATTAA


 


DS35
10
AAAGGGGCCCGCCCCATCAAGTACCTGAAGATATCCACCACCAACTTCCAAGACACCAGCA




AGCCTGTCATCTTCATTGACGGAGGCATCCACTCCAGGGAATGGATCTCACCACCCACCG




TCACTTGGGCGATCAGGAAACTGGTGGAAGATGTCACCGAACCTGACCTCCTGGAGAGGTT




CGACTGGATACTCTTGCCTATCGTCAACCCTGACGGTTATGAACACAGCCACACATCTAAC




CGTTTCTGGAGGAAGACACGTTCGGCTACCAGCATTGCATTATGCCGAGGAGTTGATGGCAA




CCGCAACTACGACTTCGCATGGAACACCGTCGGAACCAGCACCAACCCTTGCTCCGACACT




TATGGAGGCCCTACAGCCTTCTCCGAAATCGAGACCAGGGTTGTTCGTGACATCCTCCACGA




GAACCTCAGCAGAATGGCTCTGTACCTCACCATGCATAGCTTTGGTAGCATGATCCTGTACC




CTTGGGGACATGATGGTTCTTTATCCAACAACGCATTTGCACTCCAGACCGTTCTCCCTATAG




TGAGTCGTATTAAAA



















TABLE 2







Name
Name









DS2
LIM Protein 1



DS3
myosin3 light chain



DS5
chymotrypsin-like serine protease



DS6
chymotrypsin-like protease C1



DS10
chymotrypsin-like serine proteinase C3



DS12
Hydroxybutyrate dehydrogenase



DS28
Protein of unknown function



DS30
Kazal-type serine proteinase inhibitor1



DS34
Fattyacid-bindingprotein1



DS35
carboxypeptidase 4










Full length target genes were cloned based on the target gene fragments shown in TABLE 1, using the following method:
1. Extraction of Asian corn borer total RNA;

    
    
        Asian corn borer 3 instar larvae are used as the starting materials. The RNA was extracted using the regular Trizol method, and purified using the regular purification method. The RNA sample was treated with DNase. This afforded an RNA sample with a concentration of ≧300 ng/μl, a total yield of ≧6 μg, OD260/280 1.8-2.2.
    
    


2. mRNA isolation and cDNA synthesis

    
    
        The polyA containing mRNA was isolated with oligo-dT magnetic beads. Then, the first strand of cDNA was synthesized using random hexamer primers and the Superscript II reverse transcriptase reagent kit from Invitrogen.
    
    


3. Gene amplification and sequence determination.

    
    
        Using specific primers for the full length target genes shown in TABLE 5, the desired genes are cloned with RACE cloning. The RACE reactions are performed according to the instructions in the reagent box (SMARTer RACE cDNA Amplification Kit). The amplified products were analyzed on 1% agarose gel electrophoresis, and the target fragments were collected. The collected gene fragments were purified, ligated into pMD18-T vector (Takara), and transfected into E. coli strain Top10. After blue-white selection, the positive strains were subjected to sequence determination.
    
    









TABLE 5





Primers for RACE of 10 target genes from corn borer

















3′RACE










F1 (SEQ ID NO:)
F2 (SEQ ID NO:)





DS2
TTCGGCGGTGGCGCTGGCTGCCTTTC (61)
GCGGTGCCTCGCGAACGCACGCCATA (71)


 


DS3
TTCGCCAACCGCATGTCCGGCGGCTC (62)
GGACGAGGGCGGCGAAGCTGCGTAGT (72)


 


DS5
CGGCACGCGCATAAACACCAA (63)
GCCGTCGGCTCCGGCAACAACAGGCA (73)


 


DS6
TGCGCCCGCGGCGCTCCCGATATGTT (64)
ACTGGGTCGCCCGCCACTTCGTTGCT (74)


 


DS10
ACCAGGCGTGCGCCTCAGTCTTCGGA (65)
TGCTGCTGCCGGTTGCCAAGCTGGAT (75)


 


DS12
CGCTGGAGAGGGAGCGAACGTTGCCA (66)
AATCGCGTTGGACTTTGCGCC (76)


 


DS28
CCGACACCGCCACCACCCACTTCACC (67)
TTGGCCAGCTGCCCGCTAACGCCCTC (77)


 


DS30
ACCGGACCATGCAGAGGCGGGAAGGT (68)
CAACTGTCAACTGCGAGGCGAGGCGT (78)


 


DS34
ATCTTCAAGACCCCCGCCCTGA (69)
GGTCCAGGACTACGGCCCCCTTGGCT (79)


 


DS35
TCGAAGGCCGCCCCATCAAGTA (70)
ACACGTTCGGCCACCAGCATT (80)












5′ RACE










R1 (SEQ ID NO:)
R2 (SEQ ID NO:)





DS2
AGTCCAGCAACTTCTGGCACAGTCCGCA (81)
ACCGGCTACTCTCTCCTCGGCTGCGT (91)


 


DS3
AGCTGCGTGAAGTTGATCGGGC (82)
TCGGCGACCTGCTTCTGTGAGA (92)


 


DS5
TGGTGTTTATGCGCGTGCCGCCCCAG (83)
CCGCCCCAGATCCTGCCGCCATCGAA (93)


 


DS6
ACGCCACGCACGCACTGATCGCCGGA (84)
ACCGCCGGCCCTGATTCTGCCCCAACCA (94)


 


DS10
AACGGTCGCCGGGGTCCACTGAGGGT (85)
CCGTCATGGTGGCAGTGCGCAGCGGT (95)


 


DS12
ATCGGTCCTCACCGGCCCAGGGCTAA (86)
GCGAACACCATGTGGCGCAAA (96)


 


DS28
GCGCCGGGGGTAACTATCAGGGGGCA (87)
TGCTCAGGGGGCCATCGGGTCTTGGGGT (97)


 


DS30
GCAGTCACTCTCGCAAGCAGCCTGACAC (88)
GTGCAGTCTGGGGCTGGGGCGTCACT (98)


 


DS34
CGGATGACGTCGCTGTAAGGCA (89)
ACCACCTCGTGGTTCAGGGCGGGGGT (99)


 


DS35
AGTCGTAGTTGCGGTTGCCGT (90)
TCCTGATCGCCCAAGTGACAGTGGGTGG (100)









The cDNA sequences of the cloned, full-length target genes are as follows:








>DS2, 612 bp cDNA Sequence



(SEQ ID NO: 33)



   GGATTCGACCTCCGCGCACCGCAGTCTCGGCATCTTCGCCCTGTACTGTAATACGCGTTCGGGAGCTCGACTCTCGTAGCGACTCGACG



 


AACAGGATAAGTTAAGCGAGCACAATGCCTTTCAAACCAGCAGACAACCCCAAGTGTCCGAAATGCGGCAAGTCCGTATACGCAGCCGAGGA


 


GAGAGTAGCCGGTGGACTGAAGTGGCACAAGATGTGCTTCAAGTGCGGACTGTGCCAGAAGTTGCTGGACTCCACCAACTGCTCAGAACACG


 


AAGGTGAACTGTTCTGCAAAGTATGCCACGCGCGCAAGTTCGGTCCCAAGGGCTACGGCTTCGGCGGTGGCGCTGGCTGCCTTTCCATGGAC


 


GCTGGTGAACACCTGAAGGCTGAAGATGCGAATTGAGCGCGAGCAGCCATCCAGCAGAGCTAGCGGGTCGCCGACACACATCTCGGCCAACC


 


AGCGGTGCCTCGCGAACGCACGCCATACTGTACTTTAATTACTTTAGTTAGGGTTATTTATTCGCTATTGCTTAATTTATTTTGTTTATCGG


 


AACAATATTTATAATTTATACAAAATCCAATAAAAGAGTCGACTACCAACAAAAAAAAAAAAA


 


>DS2, 95 aa


(SEQ ID NO: 43)



   MPFKPADNPKCPKCGKSVYAAEERVAGGLKWHKMCFKCGLCQKLLDSTNCSEHEGELFCKVCHARKFGPKGYGEGGGAGCLSMDAGEHL



 


KAEDAN


 


>DS3, 819 bp cDNA Sequence


(SEQ ID NO: 34)



   GGGACTGCCGTCGAGCACAGTCTCTCCTTCGTCGATCGTCCAACACACAACACAATGGCGGATAAGGATAAGAAAGTAAAGAAGAAGAA



 


GGCGAAAGAAGATGCGCCAGCTGAGGAGGCGCCCGCACCAGCGGCGCCCGCAGCCAGCGGCGGCAGCGAGAGGCAATCCTCCCGCGGCAGCC


 


GCAAGGCCAAGCGCACCGGCTCCAACGTCTTCTCCATGTTCTCACAGAAGCAGGTCGCCGAATTCAAGGAGGCCTTCCAGCTAATGGACCAC


 


GACAAGGACGGCATCATCGGCAAGAACGACCTCCGCGCCACCTTCGACTCGCTCGGCAGGCTGGCGTCCGAGAAGGAGCTGGACGAGATGGT


 


GAACGAGGCCCCCGGCCCGATCAACTTCACGCAGCTGCTGACCCTCTTCGCCAACCGCATGTCCGGCGGCTCCGACGAGGACGACGTCGTCA


 


TCAACGCCTTCAAGACCTTCGACGAGGAGGGCAAGATCGACTCCGAGAGGCTCAGGCACGCGCTCATGACCTGGGGAGACAAGTTCTCCGCC


 


GACGAGGTCGACGAGGCGTACGACCAGATGGAAATCGACGACAAGGGCTTCATCGACACCACCAAGCTCATCACCATGCTGACCGCCGCCGC


 


GGAGGAGGACGAGGGCGGCGAAGCTGCGTAGTTCCACCCGCGCCAGTCTCCGCCCGACCCGCGGTTCGCAACATCTAGAACCGACTTTTTAT


 


TATAATTTCTATATGTAATTTATTGTTTCCATTTTTTTATTTATATATAATGAAAATATAGTTCTACTATTACCAAAAAAAAAAAA


 


>DS3, 205 aa


(SEQ ID NO: 44)



   MADKDKKVKKKKAKEDAPAEEAPAPAAPAASGGSERQSSRGSRKAKRTGSNVFSMFSQKQVAEFKEAFQLMDHDKDGIIGKNDLRATFD



 


SLGRLASEKELDEMVNEAPGPINFTQLLTLFANRMSGGSDEDDVVINAFKTFDEEGKIDSERLRHALMTWGDKFSADEVDEAYDQMEIDDKG


 


FIDTTKLITMLTAAAEEDEGGEAA


 


>DS5, 938 bp cDNA Sequence


(SEQ ID NO: 35)



   GCACGAGGGCCGTCCAATGAAGTCAATGAAGTCAATGAAGTCGTCCCTCTTGTTCCTGTTGGTGGTGGCGGTGGCGGCGGCGGAGCTGC



 


TGCAGCCCAACACGCGCTACCACGAGACCGAGGGCATCCCGAAGTTCCAGCTGATGAAGCAGCTGGAGGAGGGAACCGACTTCGATGGCGGC


 


AGGATCTGGGGCGGGCAGGCCGTCAGCGGCGGTACCCATCCTCACCTGGGAGGACTGTGGATCACCCTGACCACTGGACAGAACTCGATCTG


 


CGGCAGTTCGCTGGTCAGCAACACGCGCTCGGTGACGGCGGCTCACTGCTGGCGCACCAGCACCTTGCAGGCGACCATGTTCACCATCGTGT


 


GGAACTCTAACTCTATATTCTGGGGCGGCACGCGCATAAACACCAACCAGGTCATAGAGCACCCGAATTACAACGTGTGGAACTTGAACAAC


 


GATGTGGCCGTCATCATACACAACCACGTAAATTTCAACAATAATATCCAGCCAATTGCCCTGGCCACTGGCTCGCAAACCTACGCGGGAAC


 


CTGGGCAGTCGCTGCTGGATACGGCCAGACTGGCGATGGTAATTCACCGTCTGGCACTAAGTTCCAAGCCAATCTGCTGGTGATCACCAACT


 


CAGCGTGCCAGGGAACCTGGATGCCCGGCATCGTCATCGCGTCCACGCTGTGCGTGAGCACCGCGCACGGCAGCAGCACCTGCCCCGGCGAC


 


TCCGGCGGCCCGCTTGCCGTCGGCTCCGGCAACAACAGGCAACTGATCGGTATTACTTCTTTTGGAACTCAGTGGTGCGCTCAACACCACCC


 


TGCTGGATTCGCTCGAGTCACCTCGTTTGCGTCATGGTTTAACAGCCATATGTAAAAAAACTACAACGTATAAATAAAAGTATAAGTCTTGT


 


ACCAAATAAATCTTTCACTAT


 


>DS5, 287 aa


(SEQ ID NO: 45)



   MKSMKSMKSSLLFLLVVAVAAAELLQPNTRYHETEGIPKFQLMKQLEEGTDFDGGRIWGGQAVSGGTHPHLGGLWITLTTGQNSICGSS



 


LVSNTRSVTAAHCWRTSTLQATMFTIVWNSNSIFWGGTRINTNQVIEHPNYNVWNLNNDVAVIIHNHVNFNNNIQPIALATGSQTYAGTWAV


 


AAGYGQTGDGNSPSGTKFQANLLVITNSACQGTWMPGIVIASTLCVSTAHGSSTCPGDSGGPLAVGSGNNRQLIGITSFGTQWCAQHHPAGF


 


ARVTSFASWENSIN


 


>DS6, 913 bp cDNA Sequence


(SEQ ID NO: 36)



   GGGCAAAAAAAATCCTTCTCGGGCTTCCAAAATGGCAGTAAAAACCGGAATACTTTTCTTCACCCTGCTCGTGGGATGTCTAGCTATCC



 


CCAAGCCCGCGTCGGATGACCTGTCCCAGTTCTTCGAGCATGCCAACCCAGATTCCCGCATCGTCGGCGGGACGGTGGCAGCCATCGGCGCC


 


CACCCTCACATGGTGGCCATGAGCAACGGTCTCCTGATCAGGAGCTTCGTTTGCGGTGGCTCTCTCATCTCCTCCCGTACTGTTCTGACCGC


 


TGCCCACTGCATCGCTGCTGTCTTCAGCTTCGGCTCTCTGAGCAGCTCCCTCCGCGTGACCGTCGGCACCAACAACTGGAACCAGGGTGGAG


 


TGGCCTACGCCCTGGCCCGCAACGTGACTCACGAGCACTACGTCAGCCAGATCATCAAGAACGACATCGGAGTGCTGATCACCTCCTCGCCT


 


GTGGTGTTCACCAATCTCGTCCAGCCCATCACTGTGTCTTATGATTACGCCGGTGCTGGAATCCAGTCCAGAGCCGCTGGTTGGGGCAGAAT


 


CAGGGCCGGCGGTCCCATCTCCGCTCAGCTCCTCGAGTTGACCGTGACCACCATCTCCGGCGATCAGTGCGTGCGTGGCGTGGCCCAGGCCT


 


CCGTCGACTTCAACGTCGCCGCCCCACCGGTGGAACCCCACATCGAACTCTGCATCATCCACTCGCCGAACCACGGCATGTGCAACGGTGAC


 


TCCGGCAGCGCTCTAGTCCGCCTGGACCGCGGCACCCAGATCGGAATCGTGTCATGGGGCTTCCCCTGCGCCCGCGGCGCTCCCGATATGTT


 


CGTCCGAGTCAGCGCTTTCCAAGACTGGGTCGCCCGCCACTTCGTTGCTTGAATAAATGACTTGATATGATCGTGCAAAAAAAAAAAA


 


>DS6, 281 aa


(SEQ ID NO: 46)



   MAVKTGILFFTLLVGCLAIPKPASDDLSQFFEHANPDSRIVGGTVAAIGAHPHMVAMSNGLLIRSEVCGGSLISSRTVLTAAHCIAAVF



 


SFGSLSSSLRVTVGTNNWNQGGVAYALARNVTHEHYVSQIIKNDIGVLITSSPVVFTNLVQPITVSYDYAGAGIQSRAAGWGRIRAGGPISA


 


QLLELTVTTISGDQCVRGVAQASVDFNVAAPPVEPHIELCIIHSPNHGMCNGDSGSALVRLDRGTQIGIVSWGFPCARGAPDMFVRVSAFQD


 


WVARHFVA


 


>DS10, 967 bp cDNA Sequence


(SEQ ID NO: 37)



   GGGAGCGTTCATTAACACTAACAACATGAAGGTACTTCTTGGGTCAGTGGTTCTGGTCTTGGCCATCGCGGCTTCTTATGCTGAGGGGC



 


CAGTTAACTACCATCAGAGGATTGGCATTCCTGAGGCAGCTAAGATCAGAAGGACTGAGGAAGATGCGGCCAAGGCTGGTGTCGATCTCAGA


 


ATCGTTGGTGGATCCAATGTTGACATCTCCCAAGTACCTTACCAAGTTGGTCTAGTCATCCAAATCCTGTGGATCCTGACTTCTGTGTGCGG


 


AGGCAGCTTGATCTCAAACACCCGTGTGATCACCGCTGCGCACTGCCACCATGACGGTAGCGTCACCGCTCAGTCCCACACCGTCGTGCTCG


 


GCTCCAACACTATCTTCAGCGGTGGTGTCCGTCAAACCACCTCTGACATTGTCATGCACCCACAGTGGACCCCGGAGACCGTTGCTAATGAC


 


ATTGCCGTCATTAGGATTAACGCTGTTACTTTCACCAATGTGATCCAGCCCATCTCTCTGCCCAGCGGATCTCAGCTAAATAACAACTTCGT


 


AGGCCAGGTCGGAATTGCTTCTGGATTCGGACGCACTTCTGATGGTGCTAACATCCCGAACAACCAACTCGTGAGCTGGGTGAGAGTGCCGA


 


TCATCACCAACCAGGCGTGCGCCTCAGTCTTCGGACCCTTCATCTTAAGTAGCACCATCTGCACCAACGGCTCTGGTGGTATGGGCACGTGC


 


CAGGGAGACTCTGGTGGTCCTCTCGCTGTGGAAGTTGGCAACTCTAGGGTCTTGGTCGGTGTGACTTCCTTTGGTGCTGCTGCCGGTTGCCA


 


AGCTGGATTACCTGCGGCGTACGCTCGCGTCACCTCATTCATCTCTTGGATCTTGGCCATATAAGTAAAATGATCTAACGAACCCTACCTGA


 


TCTGTAACGTGTGATTGTTATTAAATAATTTAAAAAATAAAAAAAAAAAA


 


>DS10, 287 aa


(SEQ ID NO: 47)



   MKVLLGSVVLVLAIAASYAEGPVNYHQRIGIPEAAKIRRTEEDAAKAGVDLRIVGGSNVDISQVPYQVGLVIQILWILTSVCGGSLISN



 


TRVITAAHCHHDGSVTAQSHTVVLGSNTIFSGGVRQTTSDIVMHPQWTPETVANDIAVIRINAVTFTNVIQPISLPSGSQLNNNFVGQVGIA


 


SGFGRTSDGANIPNNQLVSWVRVPIITNQACASVFGPFILSSTICTNGSGGMGTCQGDSGGPLAVEVGNSRVLVGVTSFGAAAGCQAGLPAA


 


YARVTSFISWILAI


 


>DS12, 850 bp cDNA Sequence


(SEQ ID NO: 38)



   GGAAATAATTGTCATAAGCAAGATGAGTTTCAACAATAAAGTAGCGTTAGTGACTGGTGCGAGCTCTGGGATCGGAGCAGCTATTGCTC



 


TTAAATTCGCTGGAGAGGGAGCGAACGTTGCCATCGTTGGAAGAAACGCAGCTAAACTAAAAGATGTTACGGAAAGTATCTCGAAGGTCGGT


 


AACAAGCCTCTTGTGATCACCGCCGATGTTACCAAAGAAAGTGATGCTCAAAGAATCATCAACGATACAGTAAAACATTTTGGAAAACTTGA


 


CATTCTTGTCAACAATGCAGGAGTGATTCGCTATGCCAGCATTACTGAAGCAGAAGCCATGGCAGCATTTGACCATATCATGAGTACCAACC


 


TGCGTTCCGCTGTCTACATGACCAATCTGGCTGCCAAGCATCTTATTGAAACGAAAGGGAATATAATAAACATATCAAGCGTTACTGGTCAA


 


ATGGTGATGGAAAAATCGTTTGCTTACTGCACATCAAAAGCTGCCATGGATCATTTCGCGAGAGCAATCGCGTTGGACTTTGCGCCACATGG


 


TGTTCGCGTGAACAACATTAGCCCTGGGCCGGTGAGGACCGATATCGTTGAAAATATGGGAGTCAGTGCGGAGATTCAAGCAGCAGTATGGG


 


AAACATTCAAAGCAGCAACTCCTTTGAAAAGAATTAGTGAACCAAGTGAGATTGCCGAGCTAGCGGCGTTCTTGGCTAGTGACAAAGCTGTT


 


GGTATCACTGGATCAATTTACGTAACTGATAATGGAGTTTTGCTATCACGTTCAAAGTAATTCACTTAGACAAAAATATCTATTAATATACT


 


TAAGGTAACTTCTGAAAAAAAAAAA


 


>DS12, 256 aa


(SEQ ID NO: 48)



   MSFNNKVALVTGASSGIGAAIALKFAGEGANVAIVGRNAAKLKDVTESISKVGNKPLVITADVTKESDAQRIINDTVKHFGKLDILVNN



 


AGVIRYASITEAEAMAAFDHIMSTNLRSAVYMTNLAAKHLIETKGNIINISSVTGQMVMEKSFAYCTSKAAMDHFARAIALDFAPHGVRVNN


 


ISPGPVRTDIVENMGVSAEIQAAVWETFKAATPLKRISEPSEIAELAAFLASDKAVGITGSIYVTDNGVLLSRSK


 


>DS28, 1008 bp cDNA Sequence


(SEQ ID NO: 39)



   GGGGTTCTTGAAGAAACCATGACCATGGACAAACTGATTGTGTTAGCCGCCTGCATTGCCGCAGCCAGCGCACTTGGATCCTGGAAAAG



 


TGGATTGAGCGTGCGTTTTGGGGTTGGCCTCTTCGGATGGGGTTCTTCCTACTTCATTCATGTCCCCCAGACTGTGGCTGATGCCAAGAACT


 


CCCGCTGGTTGGAAACCCCAAGACCCGATGGCCCCCTGAGCAGTTTGATTATGATGTGTCCTTCCCAGAACGATGTGGTCCTCTGTGCCCTC


 


TATGATGACAATGGTGATGTGGCTGGTCTCCAGATTGCTCTGCCCACTGATAGTTACACCGGCGCTGTCTTGGACTGGGCTACCCAAGGCTA


 


CACGTACTGGACTGCACCGGCAAACTCTAATGGACAAGTTAGGAATTACTGGACCTTGCAGCAATACTTCGTTTCTGAAGCCACATTGAAGA


 


AGAGCAAGGAGGAGCGCCGCGCCTCCCGCGTGGCAGGCCGCGTACTGCAGGAGAATGCTGTGTGGGTCACCGGCTTCAACGGAGACCTGATG


 


AGGATCTCCGGCAACGCCAACGAGGTCACCGACACCGCCACCACCCACTTCACCAAACAAGCTTGCATTATTCTCATGGGTCGCCACTACTA


 


CTACAACATGACAACCGCCACCGAGTGCAGGTCTGACACCCTCCTGCCGTGGTTCCCACTGCTGGACGTGGGCACTGATCAGCTGATCGGCA


 


TGGGTTTCACGTCGTTTGGCCAGCTGCCCGCTAACGCCCTCGTCAAGGACTACTTCGAAAGGCCTAACGTGAGCAATGTTAAGTTGATAGTC


 


CCCGACGGCCCCGAATGCCTCTTCGAACTGGCGGACAGCCCTGGCCTGACCACCATGCACATCTACTACGTGGACTCACCCTGGCTCATCAA


 


CTGCATCAACAACTAGGCTCAAGAACTCTACCTCTGTCCTCTACACATGGAATGTAAATAGTTAATAAATTCTGCAGCCAAAAAAAAAAAA


 


>DS28, 304 aa


(SEQ ID NO: 49)



   MTMDKLIVLAACIAAASALGSWKSGLSVREGVGLFGWGSSYFIHVPQTVADAKNSRWLETPRPDGPLSSLIMMCPSQNDVVLCALYDDN



 


GDVAGLQIALPTDSYTGAVLDWATQGYTYWTAPANSNGQVRNYWTLQQYFVSEATLKKSKEERRASRVAGRVLQENAVWVTGENGDLMRISG


 


NANEVTDTATTHFTKQACIILMGRHYYYNMTTATECRSDTLLPWFPLLDVGTDQLIGMGFTSFGQLPANALVKDYFERPNVSNVKLIVPDGP


 


ECLFELADSPGLTTMHIYYVDSPWL INC INN


 


>D530, 798 bp cDNA Sequence


(SEQ ID NO: 40)



   ACATGGGGATGTTTTTCATCCTCGCAGTTTATCAGAACACAATTAAATTAATTAATTTAAAATGTTCAAATTAAGTTTCATTATTTTCA



 


TGTTGGTGGCTATTGCGAACGTTTTAAGCAGTGACGCCCCAGCCCCAGACTGCACCTCGCCTCTTGAGACCGGACCATGCAGAGGCGGGAAG


 


GTTGCTTTCGGCTACGATACTGACTTGGAAGGATGCAAACAGTTCATCTACGGAGGATGTGACGGCAACGGCAACCGTTACAACACTCTAGA


 


GGAGTGTCAGGCTGCTTGCGAGAGTGACTGCAACAAATAATAACGAAATGCAAGCAATCAATTGGGTATTTGACAGCACAGTCAATTGACAT


 


ACTTTTTTTAAACTGTCAAAACGCACCATTCCCTATTTTTCACATTTTGCAAAGTAGAGGGAATCTAAAGGTCATAGCAGACTTATCAACTC


 


GGAAAGGGATCATGACGAGCTATCATCGCCTTTCCCGCGTTGTCAACTGTCAACTGCGAGGCGAGGCGTTTACGTTACTGTGCGGATAGGTG


 


TGGGTTACAGTATGGAGTTTCATACAAATACTGATCGCATCGAGTTGATACGGTTACAATCCCTGTCCGTGTTGATAAGTGTGCTACGTCCT


 


TGAGTTAGCAATGATAACTAAAGCTAAGTGGTGTCGTGTTATTATCGGTAATTAGTGTCAACTACCCAATTGTATCGATATGATTTACCTAA


 


AAGATGAGAAATATTCTTTTTATTTAACTATGTATTTATTATAAAAGCAACAGCCAAAAAAAAAA


 


>DS30, 83 aa


(SEQ ID NO: 50)



   MFKLSFIIFMLVAIANVLSSDAPAPDCTSPLETGPCRGGKVAFGYDTDLEGCKQFIYGGCDGNGNRYNTLEECQAACESDCNK



 


>D534, 624 bp cDNA Sequence


(SEQ ID NO: 41)



   AGTTTGTGAAGGACTCTGATCAAAATGGCATACTTTGGAAAGGAATTCTCCTTCGAAAGGGAAGAAAATTTCGATGCATTCGCCGATTT



 


TATCGGTGCCTTTGACGCCAACGCCAAGGGCTTCATGCAGTACAAGCCGAACCAGATCCTCGAGAAGAACGGGGACTCCTACAAGCTGATCT


 


TCAAGACCCCCGCCCTGAACCACGAGGTGGTGTTCAAGTCTGGAGTGCCTTACAGCGACGTCATCCGTGAAGGTTTGACGGCTGAATCCACC


 


ATCACCGTCGATGGAGACACCTTCACTCAGGTCCAGGACTACGGCCCCCTTGGCTCCATCACCTTCAAGAGAGAGTACAGCGCCGACCAACT


 


TAAAGTGACTGTCACCAGCAGTAAATGGGACGGCGTTGCCTACAGATACTACAAGGCGTAATCTTCCTACAGTTTAACTTAAGATTTAGGTA


 


GACTTTAAATTAATTTAATAACTCTGATTTGCTATAAATGTAAGCCAACGAAGAAATAATTTTAAAATTGCAGTTATAAACTAACTATTGTA


 


AATAACGAGACACCAATTCACAAGTTTTGATCTGTTATTGTAATAAAATACTTTTTCACCGAAAAAAAAAAAAAA


 


>DS34, 133 aa


(SEQ ID NO: 51)



   MAYFGKEFSFEREENFDAFADFIGAFDANAKGFMQYKPNQILEKNGDSYKLIFKTPALNHEVVFKSGVPYSDVIREGLTAESTITVDGD



 


TFTQVQDYGPLGSITFKREYSADQLKVTVTSSKWDGVAYRYYKA


 


>D535, 1433 bp cDNA Sequence


(SEQ ID NO: 42)



   ACATGGGAAGCAGTGGTATCAACGCAGAGTACATGGGAAGCAGTGGTATCAACGCAGAGTACATGGGGAGCTATCGAGATGAAGGTTTT



 


GGCGATCGCATTGCTTTTCGTGGCGGTCTACGCCAAGCACGAGGAATATGCTGGTTACAAATCCTACTGTGTAGGACAGAAGAACCAAGCAC


 


AGCAACATGCTCTGCAGTCCTTAGAGAATGAGTTCCAGCTAGACTTTCTGGGCCGTGTGACCAGCAGCCAGGAGACCTTGGTCCTGGTCAAG


 


CCTGAATTCCAGGCTGCGTTCACCAAAAGCCTGAAAGCCTTTGGCCTCTCCTACAGGGTCCATGCCGATGACGTAGTCAAAGCGCTCCAGAA


 


TGATGATAGGATTATCGAGGAGGTGGTTCAAGAGAAGGCCAGGAATGGGGGTGCCAGGATCCCTTATGACAATTATCAGCCTCTAAGTGTCT


 


ACGACGCCTACCTCGACGACATCGCTCGTCGCTACCCCAACGTGGTCACCCTCGTCAGCCCCGCCAACTCCTTCGAAGGCCGCCCCATCAAG


 


TACCTGAAGATATCCACCACCAACTTCCAAGACACCAGCAAGCCTGTCATCTTCATTGACGGAGGCATCCACTCCAGGGAATGGATCTCACC


 


ACCCACTGTCACTTGGGCGATCAGGAAACTGGTGGAGGATGTCACCGAACCTGACCTCCTGGAGAGGTTCGACTGGATCCTCTTGCCTATGG


 


TCAACCCTGATGGTTATGAACACAGCCACACATCTAACCGTTTCTGGAGGAAGACACGTTCGGCCACCAGCATTGCATTATGCCGGGGAGTC


 


GACGGCAACCGCAACTACGACTTCGCATGGAACACCGTCGGAACCAGCACCAACCCTTGCTCCGACACTTACGGAGGCCCTACAGCCTTCTC


 


CGAAATCGAGACCAGGGTTGTTCGTGACATCCTCCACGAGAACCTCAGCAGAATGGCTCTGTACCTCACCATGCATAGCTTTGGTAGCATGA


 


TCCTCTACCCTTGGGGACATGATGGTTCTTTATCCAACAACGCATTTGCACTCCAGACCGTTGGAGTTGCTATGGCTGATGAGATCTTCACT


 


CATAGTCTCCCTAATTTCCCTAGATATTCCGTTGGCAATTCTCTTCTGACTATTGGGTACGGCGCATCAGGTGCTTCTGAGGATTACGCTCA


 


CAGCATCGGCGTGCCCCTGTCGTATACTTACGAGCTTCCAGGGTTGAACGCTGGTATGAACGGTTTCATTCTGGACCCTCGGTTCATCGAGC


 


AGGTCTGCCGGGAGACTTGGGCAGGCATCGTCGTGGGCGCCAGGAGAGCTGGCGACCTCTTCGTCCCCCATCCTTAAATTCTCTATTTGAAT


 


AAGTTGTTGATGATCTTTTTTTATAATAAACATTTTTATATTAAACAAAAAAAAAA


 


>DS35, 427 aa


(SEQ ID NO: 52)



   MKVLAIALLFVAVYAKHEEYAGYKSYCVGQKNQAQQHALQSLENEFQLDFLGRVTSSQETLVLVKPEFQAAFTKSLKAFGLSYRVHADD



 


VVKALQNDDRIIEEVVQEKARNGGARIPYDNYQPLSVYDAYLDDIARRYPNVVTLVSPANSFEGRPIKYLKISTTNFQDTSKPVIFIDGGIH


 


SREWISPPTVTWAIRKLVEDVTEPDLLERFDWILLPMVNPDGYEHSHTSNRFWRKTRSATSIALCRGVDGNRNYDFAWNTVGTSTNPCSDTY


 


GGPTAFSEIETRVVRDILHENLSRMALYLTMHSFGSMILYPWGHDGSLSNNAFALQTVGVAMADEIFTHSLPNFPRYSVGNSLLTIGYGASG


 


ASEDYAHSIGVPLSYTYELPGLNAGMNGFILDPRFIEQVCRETWAGIVVGARRAGDLFVPHP






Example 2: Extraction of Target Genes
1. Extraction of Asian corn borer total RNA

    
    
        Asian corn borer 3 instar larvae are used as the starting materials. The RNA was extracted using the regular Trizol method, and purified using the regular purification method. The RNA sample was treated with DNase. This afforded an RNA sample with a concentration of ≧300 ng/ul, a total yield of ≧6 ug, OD260/280 1.8-2.2.
    
    


2. Isolation of mRNA and synthesis of DNA

    
    
        The polyA containing mRNA was isolated with oligo-dT magnetic beads. Then, the first strand of cDNA was synthesized using random hexamer primers and the Superscript II reverse transcriptase reagent kit from Invitrogen.
    
    


3. Gene amplification and sequence determination.

    
    
        Using specific primers for the target genes shown in TABLE 3, the desired genes are amplified. The collected gene fragments were purified, ligated into pMD18-T vector (Takara), and transfected into E. coli strain Top10. After blue-white selection, the positive strains were subjected to sequence determination.
    
    









TABLE 3







Primers Used In the Synthesis of dsRNA for the 10 Target Genes









Name
Forward Primer
Reverse Primer





EYFP
TAATACGACTCACTATAGGGAGGACGACGGCA
TAATACGACTCACTATAGGGGAACTCCAGCAGG



ACTACAAG(SEQ ID NO: 11)
ACCATGT(SEQ ID NO: 12)


 


DS2
TAATACGACTCACTATAGGGAGAGCACGAGGG
TAATACGACTCACTATAGGGAGAGCGACCCGCT



CAGTCTCGGC(SEQ ID NO: 13)
AGCTCTGCTG(SEQ ID NO: 14)


 


DS3
TAATACGACTCACTATAGGGAGACGCACCGGCT
TAATACGACTCACTATAGGGAGACTGGCGCGGG



CCAACGTCTT(SEQ ID NO: 15)
TGGAACTACG(SEQ ID NO: 16)


 


DS5
TAATACGACTCACTATAGGGAGACTGCGGCAGT
TAATACGACTCACTATAGGGAGATGGACGCGAT



TCGCTGGTCA(SEQ ID NO: 17)
GACGATGCCG(SEQ ID NO: 18)


 


DS6
TAATACGACTCACTATAGGGAGAGTCCAGAGC
TAATACGACTCACTATAGGGAGACAAGCAACGA



CGCTGGTTGGG(SEQ ID NO: 19)
AGTGGCGGGC(SEQ ID NO: 20)


 


DS10
TAATACGACTCACTATAGGGAGAGCGTCACCGC
TAATACGACTCACTATAGGGAGACCGGCAGCAG



TCAGTCCCAC(SEQ ID NO: 21)
CACCAAAGGA(SEQ ID NO: 22)


 


DS12
TAATACGACTCACTATAGGGAGACGCTGGAGA
TAATACGACTCACTATAGGGAGACCTCACCGGCC



GGGAGCGAACG(SEQ ID NO: 23)
CAGGGCTAA(SEQ ID NO: 24)


 


DS28
TAATACGACTCACTATAGGGAGAGCAGCTGGC
TAATACGACTCACTATAGGGAGACGGCGCTGTCT



CAAACGACGTG(SEQ ID NO: 25)
TGGACTGGG(SEQ ID NO: 26)


 


DS30
TAATACGACTCACTATAGGGAGAGACCGGACC
TAATACGACTCACTATAGGGAGAGCACACTTATC



ATGCAGAGGCG(SEQ ID NO: 27)
AACACGGACAGGG(SEQ ID NO: 28)


 


DS34
TAATACGACTCACTATAGGGAGAGCCTTTGACG
TAATACGACTCACTATAGGGAGATCTGTAGGCAA



CCAACGCCAAG(SEQ ID NO: 29)
CGCCATCCCA(SEQ ID NO: 30)


 


DS35
TAATACGACTCACTATAGGGAGACAGCCCCGCC
AACGGTCTGGAGTGCAAATGCGT



AACTCCTTCG(SEQ ID NO: 31)
(SEQ ID NO: 32)









Wherein, EYFP is an enhanced yellow fluorescence protein gene, used as an external gene control.
Example 3: dsRNA Synthesis
The methods described in this invention are applied in the studies of corn borer. The above-described 10 target gene fragments and an external control (EYFP) are cut from the pMD18-T vector (Takara Co.) and ligated into a modified pET-22b plasmid to obtain dsRNA that can be used in bioassays. The specific construction methods are as follows:
Methods for dsRNA Synthesis:







(1) Primer Sequences








(Sense Strand) F:
TCG GGATCC XXXXXXXXXX


 


(Sense Strand) R:
GAC AAGCTT XXXXXXXXXX


 


(Antisense Strand) F:
CTG CATATG XXXXXXXXXX


 


(Antisense Strand) R:
TCG TCTAGA XXXXXXXXXX






Wherein TCG/GAC is a protection location, the underlined sequences are the forward strand BamHI/HindIII restriction site and the reverse strand NdeI/XbaI restriction site. XXX represents different primer sequences for different genes. The reverse strands are reverse complementary sequences, see TABLE 3.
Using Asian corn borer cDNA as a template to perform forward and reverse stand PCR amplification to obtain PCR products (amplification conditions: 94° C. 3 min, 94° C. 30 s, 55° C. 30 s, 72° C. 30 s, 72° C. 10 min). PCR products were analyzed on 1% agarose gel electrophoresis.
The obtained PCR products are separately ligated into modified pET-22b plasmid (the modified plasmid is obtained by adding “intro” between the NcoI and MscI sites). That is, the sense strand is ligated at the enzyme cut sites and then the antisense strand is ligated at the enzyme cut sites. The “intro” sequence is located between the two enzyme cut sites. After proving successful ligation, the final product is a closed circle with two inserted fragments.
The ligation products were transformed into HT115(DE3) (purchased from AddGene) competent cells (this bacteria strain is a defective E. coli strain, with the following characteristics: F-, mcrA, mcrB, IN (rrnDrrnE)1, rnc14::Tn10 (DE3 lysogen: lavUV5 promoter-T7 polymerase). Under tetracycline induction, through the influence of Tn10 transposon, induce RNase III gene loss. When induced with IPTG, HT115 may specifically express T7 polymerase, which through recognition of the T7 primer sequences at the insertion points, can produce and fold the product to produce dsRNA. The positive clones may be screened by blue-white selection.
Pick a single clone and transfer it into an LB culture medium containing 100 μg/ml ampicillin and 12.5 μg/ml tetracycline. Culture it at 37° C. for 10-14 hours.
Dilute the culture 100 folds and added it into a 2×YT culture medium (peptone 16 g, yeast extract 10 g, sodium chloride 4 g, dissolved in 1 L water, pH 7.0) until OD600 reached 0.4. Then, 0.4 mM IPTG was added and cultured in a shaker for 4 hours to obtain the dsRNA expression products of the genes. (see, Ravi S Kamath, Maruxa Martinez-Campos, Peder Zipperlen, Anderw G Fraser, J. Ahringer, Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans, Genome Biol 2, 0002.1 (2000).
The bacteria obtained above may be used directly. Alternatively, one may purify the recombinant plasmids and isolate dsRNA for use as pesticides.
Example 4: dsRNA Purification
Purify the dsRNA expression products obtained in the above described step. A method for purifying recombinant plasmids and isolating dsRNA is as follows:
(1) take 2 ml of bacteria culture for a small scale plasmid extraction to prove that the plasmids have been amplified. The remaining bacteria culture is put in a 50 ml centrifuge tube and centrifuged at 4° C., 5500 rpm for 10 min Remove the LB culture medium as much as possible by placing the centrifuge tube upside down;
(2) add 0.6 ml alkaline lysis buffer I (50 mmol/L glucose, 25 mmol/L Tris-HCl (pH 7.6), 10 mmol/L EDTA, dissolved in 1 L sterile water and sterilized at high temperature, add 1% RNase 0.5 ml). Resuspend the bacteria by pipetting or vortexing. Add 1 ml freshly prepared 10 mg/ml lysozyme, 13.3 ml freshly prepared alkaline lysis buffer II (0.2N NaOH, 1% SDS), and mix well by gentle rotation. Leave it at room temperature for 5-10 minutes. Do not leave it for more than 10 minutes. Add 10 ml ice cold alkaline lysis buffer III (5 mol/L potassium acetate 60.0 ml, glacial acetic acid 11.5 ml, H2O 28.5 ml) and mix well by gently inverting the tube. Place the centrifuge tube on ice for 10 minutes;
(3) centrifuge at 4° C., 20,000 g for 30 minutes. Based on the volume of the supernatant, add 0.6 fold volume of isopropanol and put into a new 50 ml centrifuge tube (if the volume is too large, then separate it into two tubes). Thoroughly mix it and then leave it at room temperature for 10 min. Centrifuge it at room temperature, 12,000 g for 15 min; (4) discard the supernatant. Wash the tube wall with 70% alcohol and discard the alcohol. Place the tube upside down to dry it for 10-15 min. Dissolve the precipitate with 3 ml water, and place it on ice to precool it to 0° C. Add an equal volume (3 ml) of ice cold 5 mol/L LiCl. Mix well and then centrifuge at 4° C., 12,000 g for 10 min;
(5) transfer the supernatant to a new 50 ml centrifuge tube. Add an equal volume (6 ml) of isopropanol. Mix well and centrifuge at room temperature, 12,000 g for 10 min;
(6) after discarding the supernatant, place the centrifuge upside down to allow the liquid to drain dry. Wash the precipitate and tube wall with 70% alcohol at room temperature. Place the tube upside down to allow the alcohol to flow out and drain, thereby the alcohol in the precipitate would evaporate;
(7) use 500 μl water containing RNase A (20 μg/ml) to dissolve the nucleic acid precipitate. Transfer the solution to a 1.5 ml centrifuge tube and digest at 37° C. for 30 min;
(8) add an equal volume (500 μl) of phenol:chloroform. Mix well by vortex and centrifuge at the maximum speed at 4° C. for 2 min. Transfer the supernatant to another centrifuge tube (if there is too much protein film, repeat this step until protein is depleted);
(9) add an equal volume (500 μl) of chloroform. Vortex well to extract phenol. Centrifuge at the maximum speed at 4° C. for 2 min Transfer the supernatant to another centrifuge tube. Add 2 volumes of absolute ethanol (1 ml). Mix well and leave it on ice bath for 15-30 min to precipitate the nucleic acid. Centrifuge at the maximum speed at 4° C. for 5 min. Discard the supernatant and place the tube upside down to allow it to dry;
(10) add 1 ml of 70% ethanol, and wash the precipitate by inverting the tubes several times. Centrifuge it at 4° C. at maximum speed for 2 min. Discard the supernatant and place the tube upside down to allow ethanol to dry by evaporation;
(11) dissolve the plasmid precipitate with 1 ml water. Add 0.5 ml PEG-MgCl2 solution, mix well and leave it at room temperature for not more than 10 min Centrifuge at room temperature at the maximum speed for 20 min to recover the plasmids;
(12) resuspend the precipitate with 0.5 ml 70% ethanol to remove PEG. Centrifuge at room temperature at the maximum speed for 5 min. Repeat the washing once. Discard ethanol and let it sit for 10-20 min to allow ethanol to evaporate;
(13) dissolve the wet plasmid with 200 μl ddH2O or TE(pH 8.0). Store the solution at −20° C.;
(14) digest the obtained plasmid with BamHI/HindIII to obtain specific dsRNA.
The above dsRNA is analyzed with electrophoresis after purification. For example, DS12 and DS28, having sizes consistent with the target fragments, were obtained as shown in the electrophoregram. The electrophoresis results are shown in FIG. 4.
Example 5: dsRNA Applications—Spray
Insect body permeation experiment: to prove that dsRNA can permeate (penetrate) insect body wall, inventors synthesized fluorescence labeled double stranded RNA (corresponding to DS12 and DS28). Cy3 fluorescence dye labeled dCTP was used to synthetize dsRNA (Ambion, MEGAscript RNAi Kit). After synthesis, 0.5 μl dsRNA was dropped on the back at the fifth segment of larvae of Asian corn borer. The larvae was then monitored under fluorescence microscope, as shown in FIG. 5A. Afterwards, the larvae were monitored every half an hour. It was found that dsRNA has penetrated into larvae body by 1 hour, see FIG. 5B. After 4 hours, dsRNA had spread to the entire body, see FIG. 5C.
The inventors use the above obtained dsRNA (dissolved in ddH2O, at a concentration of 50 μg/ml) to spray larvae of Asian corn borer (application amount is 300 μl/300-500 larvae). Five days after the application, dsRNA corresponding to 9 target genes (DS2, DS3, DS6, DS10, DS12, DS28, DS30, DS34, DS35) achieved over 70% mortality, as shown in FIG. 2. The blank control (CK) and an exogenous gene control (EYFP) did not produce appreciable mortality. Therefore, it is clear that RNA can entire insect body from body surface to inhibit target genes, resulting in insecticide effects. Thus, other nucleic acid inhibitors based on the target genes of the present invention may also be used as sprays to achieve insect killing effects.
qRT-PCR protocols are based on the operation procedures in the SYBR reagent box from TARAKA Co. qRT-PCR results proved that silencing of target gene can cause death, proving the reliability of the invention, as shown in FIG. 3.
Results
Through the dsRNA insect body permeation experiments, it is proved that it is possible to control pests using dsRNA spraying methods.
Example 6: Application of Host Expressing dsRNA—Feeding
The bacteria expressing dsRNA from EXAMPLE 3 were used in direct feeding experiments:

    
    
        1. As described in EXAMPLE 3, culture the bacteria that express dsRNA at 37° C. until the culture reached an OD600=about 0.8. Wait until OD600 reaches 0.2, add 0.4 mM IPTG, and culture at 37° C. in a shaker until OD600=about 2.0.
        2. Mix the bacteria culture with the feed for Asian corn borer (0.1 ml/g feed). Feeds are replaced daily. Use a bacteria culture that does not express dsRNA as a blank control. In each treatment group, there are 50 larvae. They are observed daily to observe death rates. After feeding 1-7 days, analyze the results. The results are shown in FIG. 4. Feeding with hosts expressing dsRNA resulted in insect killing. In reality, it is the nucleic acid inhibitory effects of the dsRNA that produced insect killing. Therefore, the target gene dsRNA or other forms of nucleic acid inhibitors all can achieve insect killing via feeding.
    
    









TABLE 4







Corn borer larvae death rates after feeding on 20 μg/ml bacteria


synthesized dsRNA










Serial No.
Death Rate (%)







CK
10



dsEYFP
10



DS2
50



DS3
56



DS5
32



DS6
20



DS10
64



DS12
48



DS28
42



DS30
46



DS34
40



DS35
26










Example 7: Shortened Forms of DS12 and DS28 and Their Effects
The inventors designed shortened dsRNA fragments based on DS12 (SEQ ID NO: 6) and DS28 (SEQ ID NO: 7).
DS12-M1 dsRNA: the methods for the synthesis and purification are as described in EXAMPLES 3 and 4. The difference is that the target gene fragment is at locations 1-488 in SEQ ID NO: 6.
DS12-M2 dsRNA: the methods for the synthesis and purification are as described in EXAMPLES 3 and 4. The difference is that the target gene fragment is at locations 7-491 in SEQ ID NO: 6.
DS28-M1 dsRNA: the methods for the synthesis and purification are as described in EXAMPLES 3 and 4. The difference is that the target gene fragment is at locations 1-433 in SEQ ID NO: 7.
DS28-M2 dsRNA: the methods for the synthesis and purification are as described in EXAMPLES 3 and 4. The difference is that the target gene fragment is at locations 4-433 in SEQ ID NO: 7.
As described in EXAMPLE 5, the above four (4) dsRNAs are sprayed on larvae of Asian corn borer (application amount 3000300-500 larvae). Five (5) days after application, these dsRNAs caused over 70% death rate in these larvae.
Example 8: Compositions
The formulation of agriculturally acceptable carrier for dsRNA (1 L system):
50 mM NaHPO4, pH 7.0, 10 mM β-mercaptoethanol, 10 mM EDTA, 0.1% sodium lauryl sarcosine, 0.1% Triton X-100, add H2O to make it to 1 L
The above formulation is a buffer formulation. It is only necessary to add any purified dsRNA into the buffer solution according to the desired concentration, such as 50 mg/L. One may also prepare a concentrate if necessary.
Example 9: Synthesis of Cotton Bollworm Full Length Target Genes and dsRNA
The full-length target genes described in EXAMPLE 1 are compared with the databank of cotton bollworm transcripts (Wang et al., PLoS ONE, 6(4):e18644; and Chinese Invention Patent Application No. 201010197328.9) to obtain 8 cotton bollworm target gene fragments that are homologous with the corn borer target genes described in EXAMPLE 1. Their full length sequences are as follows:








>HarmDS2



(SEQ ID NO: 53)



   ATTCGAACATCGCGCACCGCAGTCTCGGCATCTACGCCCTGAACTGTATACGCGTCCGGGAGATCATCCCGCAGCGACTTCGACGAACA



 


GGATAAGTTAAGCGAGCACAATGCCTTTCAAACCAGCAGATAACCCTAAGTGCCCTAAATGCGGCAAATCAGTATACGCAGCTGAGGAGAGA


 


GTCGCCGGAGGACTCAAATGGCACAAAATGTGCTTCAAGTGCGGCCTGTGCCAGAAGTTGCTGGACTCCACCAACTGCTCAGAACACGAAGG


 


TGAACTGTACTGCAAAGTGTGCCATGCACGTAAATTCGGACCAAAAGGCTACGGCTTCGGCGGTGGTGCTGGCTGCCTGTCCATGGACACTG


 


GTGACCACCTGAAGGCTGAGAATGCGAATTGAGCGAGCAGCCCTCCAGCAGAACTAGCGGGTCGCCGACACACATCTCGGCCCACCAGCGAC


 


GCCTCGCGAACGCACGCCATACTGTACTTTAAATTACTCTAGTTAGGATTATTTATTCGCTATCGCTTAATTTAATTTGTTCATCGGTATTA


 


TTTATTATTTATAAAAAACACAAATAAATAAAACAGTCGACTGTTTTATTTATTTGTGTTTTTTATAAATAATAAATAATACCGATGAA


85.3% homology with the related sequences from corn borer.


 


>HarmDS5


(SEQ ID NO: 54)



   ACATGGGGAGTATTTGTTAGATTAGGTACGTTACCAGTGTTGCGTCTTGTAGAACATTAGTTTAATTTTTTTGTAGTTTCAGCTCCTAG



 


TTTTGCCTGGAAACACGATGAAAACCTTCATTGTAGTGTGTTTGGCTCTGGCTAGCTTCGCCTGTGCGGAGCAGGGATCTTTCCCTGGGTAC


 


TCCACGTTTGGGTACCTAGAGAAGTATGCTATTCCTCATGCGGAGAAACTTCGCGCGGCTGAGGAAAAGTTCCTCGCTAGCCAGTCTGGCTC


 


CAGGATCGTAGGTGGAGTTCCCGCTGGCCAGGGACAGTACCCATACCAGGCTGGTCTCCTCCTCTCCATCATCGGTTTCGAAGGCAACGGTA


 


TCTGCGGAGGCTCCCTGATCAGCGCCAACCGAGTAGCAACAGCCGCCCACTGCTGGTTCGACGGTATCCACCAAGGATGGAAGGTCACAGTT


 


GTGCTCGGTTCCACCCTGCTGTTCTCTGGAGGCACTCGTCTTGAGACCAGTGTGGTCGCCATGCACCCTAACTGGACTCCTGCACTCGTCCG


 


CAATGATGTTGCTGTGATTTACTTGCCCAACTCYGTRCAGATTTCAGCCAATATTGCACCAATTGCTTTGGCTAGCGGMTCTTCAGAATTCG


 


CCGGTGTCTCCGCCATTGCCTCCGGTTTTGGATTAACCAGCTCTAGCGGACAAATCACCGCTAACCAGTTCCTGAGCCACGTCAACCTGAAC


 


GTGATCACCAACATCGCCTGCAGCGTCGCCTTCCCCTTCATTGTCCAGCCTTCCAACATCTGCACCAGTGGTATCGGAGGTGTTGGTACTTG


 


CAGCGGTGACTCTGGTGGTCCTCTGGTCACCAACCAGAATGGACAGAACGTCTTGATTGGTATCACTTCCTTCGGCTCGGCTTTCGGCTGCC


 


AGGTCAACCTGCCCTCAGTCTTCGCTCGTGTCACATCATTCGTCTCTTTCCTCAACCAACATTTGTAATTCTGAACAAACTGTAAACTATAC


 


TGTAAATAAGACTGGAGTTGGAATCTTTTCCAGCATATTCGTTGTATTTTTACAAAAAAATTGAAGCTATATAATAAGCAATAAAATAAAAT


 


CTGCTCTCGTAAAAAAAAAAAA


60.7% homology with the related sequences from corn borer.


 


>HarmDS6


(SEQ ID NO: 55)



   TTTTTTTTTTTTTTTCATTCAAATTCATTTATTTCTCCCCATTAAATTAAGATGCAGTCTTAAGCAGTTTCCAAAGTCCTTTTATCGGA



 


ATATTTACAAGTCCTTTAGTCTGTCTATTTAGACTACATTAGCCTGGAGCCAGGACTGGTAGGCGCTGACTCTGACGAACATGTCGGGGGCG


 


CCGCGGGCGCAGGGGAAGCCCCAGGACACGATGCCGAACTGCTGGCCGTTGTCGGCGCGGGTCAGAGCGCTGCCGGAGTCACCATTGCAAGT


 


TCCGAATCCAGGAGCGTGGAAGGTGCAGACCTCGATGTGAGGTTCAACGGGAGGAGCGCGTACATTCAGCTCGACGGAGGCGCGGGCCACGC


 


GAGCCACGCAGTCGTTACCGTCGATGGTGGTGGGGAACAGCTCCAGGAGAGTGGCTGAGAGGGCACCGCCAGCCCTGATTCTACCCCATCCA


 


GCGACCCTAGCGTTAACACCACCAGGGATGTGAGCGTAAGTCAGAGGCACAGTCCTGACGAGGTTGTTCAGAGCCACGTTGTTGGAGGTGAT


 


GAGGATACCGATGTCGTTCTTGATGGTGGCAGACACGTAGTTGGGGTGGGTGACGTTGCGGGCCAAGGTGTAGGCCACGCCGCCGCTGTTCC


 


AGCGGTTTGTGCCGACTGTCACGCGGAGAGAGTTAACCAGCGAGCCACCACTGAACACCGCAGCGATACAGTGAGCAGCTGTCAGCACAGTC


 


CTAGTCGTGATCAAGGAACCGCCGCAGAGGAAGCTCCTCACCAGCACGCCACTGGACATGGCCACCATGTGAGGGTGGCTGCCCACAGCCGC


 


CTGGGTGCCGCCAACGATGCGAGCGCTGGCGTCAGTGTGGTCGAAGAAGCGTGACATGTCATCTTCGGGCGCGGGGAGGGCAATACACCCAA


 


CCAGGAGCGAGATCACCAGAAGTCCGGTTTTGAAGTCCATGTTTAACAACG


71.9% homology with the related sequences from corn borer.


 


>HarmDS10


(SEQ ID NO: 56)



   ATCCAAGAATTCGCACGAGACAAATCAACATGAGCTGTCCCTAGGAGTGTGCTAGCTTGGCCGTCGCCGTATCGGCAGTGGAGATCGCC



 


ACTCCTGATGCCGACAGCCCTGTCTTCGGCTACCACGCCAAGTTTGGTATTGCTGAGGCTGCGAGGATCAAGAGCGCGGAGGAAGTTCAGAG


 


CTTCAACGGCCAGAGGATCGTTGGAGGATCCATCACCAACATTGCCAACGTCCCATACCAGGCTGGTCTTGTGATCACCATCTTCATCTTCC


 


AATCCGTGTGCGGTGCTTCCCTCATCTCCCACAACCGCCTGGTGACTGCTGCTCACTGCAAATTCGACGGTGTCTTGAACGCTAGCTCCTTC


 


ACCGTTGTGCTTGGCTCCAACACCCTGTTCTTCGGCGGTACTCGCATCAACACCAATGATGTCGTCATGCACCCCAACTGGAATCCTGCTAC


 


CGTTGCCAATGACATCGCTGTCATTCGCATCAGTTCCGTCAGCTTCAACAATGTGATCCAGCCCATCGCTCTTCCCAGTGGAGACGAACTCA


 


ACAACCTCTTCGTCGGCGCCAACGCTCTTGCCTCCGGATTTGGCCGCACTAGCGACAGTGGAAGCATTGGTACCAACCAACAGCTGAGCTCT


 


GTGACCATCCCCGTGATCACCAACGCTCAGTGCGCTGCCGTGTACGGCCCCGCCTTTGTGCACGCCTCCAACATCTGCACCAGCGGCGCCGG


 


CGGCAAGGGTACTTGCAACGGTGACTCCGGTGGCCCTCTCGCTGTCGACAGCAACAACAGGAAGATCTTGATCGGTGTTACTTCATACGGTG


 


CTGCTGACGGTTGCGCCGCTGGTTTCCCTGCTGCCTTCGCCAGAGTCACCTCCTTCGTCAGCTGGGTCCAGTCCCAATAATCTCCTCCTCTC


 


TTAAACTTATAATGCTTAAATTAAATTTATTTTACTTCAAAAAAAAAAAAAAA


65.2% homology with the related sequences from corn borer.


 


>HarmDS12


(SEQ ID NO: 57)



   AGAAACTGAAGAATACTGCCAAGAAATGTGGAAACCCTTTAGTGATCGTCGCTGATGTCACAAAAGAAGACGACGTCAAAAGAATTGCC



 


AGTGAAACGTTGAAACATTTTGGGAAACTCGATGTTCTGGTCAACAATGCTGGCATTTGTCCATTTGCTAGTATTCAAGCTGACAACGCAAT


 


GCAGGTCTACGATGAAATAATGTCTACAAACCTCCGGTCTACCGTTCTACTGACACATCTTACCGTCCCTGAACTTGTGAAAACTAAAGGCA


 


ACATTATCAATATTTCAAGTGTTGCTGCTTTCAAAGTCGCTCTAGGTCTTTTTGCGTACTGTGCGTCGAAGGCAGCTATGGATCACTTCTCT


 


AGAGCGATTGCACTAGAGCTGGCTCCAAGTGGTGTACGTGTAAATGTAGTCAATCCAGGACCCGTGGCGACTGACATCGGTGCTACCATGTT


 


CCCAACAAAAGAGGAACAAGACAATTTCTTTAAAAAAGTCGTGGATGGAACTGCATTGGGCAGGATATCGGAGCCTGAAGAAATAGCTGATA


 


TTGTTCTGTTCCTAGCGAGTGATAAAGCTAGAGGGATCACCGGTTCAAGTTATGTTTCTGATAATGGATATTCGGTTAAAGGCGTACAAGCT


 


TGATTAATTTTATTAATAAACGTAATTTTAAATAGTGC


68.8% homology with the related sequences from corn borer.


 


>HarmDS28


(SEQ ID NO: 58)



   AGACCGGCCCTACCCTCCCAAGTGGCTATGAGAACCTGGTACTGTATGGCCCCGCTGACGACAACACCCTCAACTTATACTACGATGAC



 


AACTATCAGATTGCTGCATTCCAAATTGGTCTGGACAAAGAACAAATAAGCGATTCGGTATACGATTTCGAAAATCAAGGATTCGCAAGCTG


 


GACCACTACATTGTCTAATGGCACATCTAGAGATTATTGGACCATCAGAGCATACTTTTCCACTGCTGATTATCTTGCGACTGACGCAACAA


 


CTCGCAACTCTTCAAGAAATACTGAGACGTTGATCCAGGGTGGTTCCATGGTAGTGACTGGTTTCAACGGAGAATTGTACACCATTTCCTCC


 


GACCCTACCGTACTTGCCGACACAAGCGTCAGTGGGTTCACAGAACAAGCCTGCATGATATATATGGGTCACCATTTCTACTACAACATGAC


 


TACAAGCTTGGAGTGCGCTGAAGGAAGGCTGTTCCCCTGGTTCCCACTTTCCTACAACGGAGTAGTGATGGGCATTGGTTTCAACTTTATCG


 


GCAAATACGACGTGAGACCTGACAATTTCAATTATTTCGAAAGCCCTGGAGTAGCAGCTGTTAAGATCATCGTACCAAAAGGCCCGCAATGT


 


TTCTACGAGTTAGCAGAAAACCCCGGCGTGG


71.5% homology with the related sequences from corn borer.


 


>HarmDS34


(SEQ ID NO: 59)



   TTCAGTCAACATGTCTTTCCTTGGCAAAACTTACACCTTCGTCAAACAGGAGAATATGGACGGATTCCTGAAATCTGTCGGTCTCCCTG



 


ACGACAAAATCGAGCCAGTCCTGAAGTTCACTCCTGAACAGAAGATCATTCAGGAAGGTGATGGCTACAAGTACATCACTCAGGGTCGCGAT


 


GGCCCTAGAGAAGTCACATTCAAGTCCGGAGTAGAATTCGACGATCTTATTGGACCTGAGAAAATTCCCGCTAAGACTACATACGTCGTTGA


 


TGGCAACAAAGTGACACAGACCATCAAATCAGCTATGGGAGTCGGCACCTTCACCAGGGAGTTCGTTGGCGATGAACTTATCATCACCATGG


 


TCACCGACAAATGGGACGGCGTTGCCAAGAGATAC


73.2% homology with the related sequences from corn borer.


 


>HarmDS35


(SEQ ID NO: 60)



   CATTCCTCGAAAGGTCGTCCCATCAAGTACGTCAAAATCCTCCACAACCTACTTTGAAGACCACAGCCAAGCCTGTCATCCTCATCGAT



 


GGTGGTATCCACGCCAGGGAAATGGATCTCTCCCCCCACTGTTACCTTGGGCTATTCATAAGCTGGTTGAAGATGTTACTGAAAGAGATCTT


 


CTAGATAATTTTGACTGGATCCTCTTGCCTGTGGTCAACCCTGATGGATATAAATTCACTTTTACCAATTCCCGTTTCTGGCGTAAGACTCG


 


TTCCACGGACCAGCACGTTTTAAGCGGTATCTGCCCAGGAGTCGACGGTAACCGCAACTATGACTTCTTCTGGAACACCGTIGGTACCAGCA


 


ACACCCCATGCTCAGACGTCTACGCTGGATCCAGAGCCTTCTCCGAAGTCGAAACCAGGGTCGTCAGAGATATCCTCCATGAACATTTAGCA


 


CGCATGGCTCTGTACATCACCATGCACAGTTTCGGAAGCATGATCTTATACCCATGGGGTCATGATGGCTCCCTATCTCATAACGGCCTTGG


 


TCTTCATACGGTGGGAGTTGCTATGGCAACGGCAATCAATCAGAATTCTCTATCTCACTTCCGATCTTATGTTGTTGGAAATTCAGCTTTAG


 


TTCTGAACTATCCAGCGGCTGGTGCGTCAGAAGATTATGCTCATCAAATTGGCGTGCCTCTATCCTATACTTTTGAGCTACCTGGTCTATCC


 


AACACATTACTTGGATTCAATTTGAACCCTAGGTACATTCAACAAGTATGCAATGAAACTTGGCAAGGTCTCATCGTTGGAGCTAGGAGAGC


 


TGGTGATTTATTTAGAAATAAAAAACTTTAAAGACTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA






79.9% homology with the related sequences from corn borer.
Using the full-length target gene sequences of cotton bollworm as PCR amplification template and the primers of TABLE 6, dsRNA of 8 cotton bollworm target genes are obtained using the methods described above.







TABLE 6







Primers Used in the Synthesis of dsRNA of 8


Target Genes of Cotton Bollworm










SEQ




ID



Name
NO:
Primer (5′→3′)





Harm ds2 F
101
TAATACGACTCACTATAGGGAGAACATCGCGCACCGCAGTCTC


 


Harm ds2 R
102
TAATACGACTCACTATAGGGAGATCGCTGGTGGGCCGAGATGT


 


Harm ds5 F
103
TAATACGACTCACTATAGGGAGACCCGCTGGCCAGGGACAGTA


 


Harm ds5 R
104
TAATACGACTCACTATAGGGAGACAGCCGAAAGCCGAGCCGAA


 


Harm ds6 F
105
TAATACGACTCACTATAGGGAGAAGCCAGGACTGGTAGGCGCT


 


Harm ds6 R
106
TAATACGACTCACTATAGGGAGAGCCATGTCCAGTGGCGTGCT


 


Harm ds10 F
107
TAATACGACTCACTATAGGGAGATGTGCTAGCTTGGCCGTCGC


 


Harm ds10 R
108
TAATACGACTCACTATAGGGAGATGCAAGTACCCTTGCCGCCG


 


Harm ds12 F
109
TAATACGACTCACTATAGGGAGATGTGGAAACCCTTTAGTGATCGTCGC


 


Harm ds12 R
110
TAATACGACTCACTATAGGGAGATCAGGCTCCGATATCCTGCCCA


 


Harm ds28 F
111
TAATACGACTCACTATAGGGAGAGACCGGCCCTACCCTCCCAA


 


Harm ds28 R
112
TAATACGACTCACTATAGGGAGATGGGAACCAGGGGAACAGCCT


 


Harm ds34 F
113
TAATACGACTCACTATAGGGAGATTCAGTCAACATGTCTTTCCTTGGCA


 


Harm ds34 R
114
TAATACGACTCACTATAGGGAGAGTATCTCTTGGCAACGCCGTCCC


 


Harm ds35 F
115
TAATACGACTCACTATAGGGAGAAGACCACAGCCAAGCCTGTCA


 


Harm ds35 R
116
TAATACGACTCACTATAGGGAGATCTTCTGACGCACCAGCCGC









Example 10
Applications of dsRNA of Cotton Bollworm Target Genes—Spray
The inventors sprayed the dsRNA obtained in EXAMPLE 9 (dissolved in dd H2O at a concentration of 50 μg/ml) directly on larvae of Asian cotton bollworm (application amount 300 μl/300-500 larvae). Compared with the blank control (CK) and an exogenous gene control (EYFP), the dsRNA corresponding to each target gene increased the death rate of cotton bollworm (TABLE 6, and FIG. 6). Therefore, it is clear that nucleic acid inhibitors based on target genes of the invention can cause death in pests.







TABLE 7







Death Rates of Cotton Bollworm larvae Feeding on dsRNA











1 Day
3 Days
5 Days
















CK
 5.56 ± 6.36
12.50 ± 4.17 
16.67 ± 0.00



EYFP
 6.25 ± 2.95
14.58 ± 2.95 
18.75 ± 2.95



DS2
 16.67 ± 11.79
54.17 ± 17.68
 70.83 ± 23.57



DS5
10.42 ± 2.95
22.92 ± 8.84 
22.92 ± 8.84



DS6
29.17 ± 5.89
39.58 ± 8.84 
43.75 ± 8.84



DS10
 20.83 ± 17.68
27.08 ± 14.73
33.33 ± 5.89



DS12
22.92 ± 2.95
37.50 ± 11.79
39.58 ± 8.84



DS28
10.42 ± 2.95
37.50 ± 5.89 
45.83 ± 5.89



DS34
25.00 ± 5.89
45.83 ± 5.89 
56.25 ± 8.84



DS35
29.17 ± 5.89
50.00 ± 11.79
 58.33 ± 11.79










All literatures discussed in this invention are incorporated by reference in this application, as if they were individually cited as references. In addition, it should be understood that after read the disclosure of the invention, one skilled in the art would know how to vary or modify the invention. These equivalents should fall within the scope of the claims in this application.

## Claims

1. A dsRNA having the following structure:



wherein
Seq′Forward or Seq′Reverse contains an RNA sequence complementary to at least 21 consecutive nucleotides of the nucleotide sequence of SEQ ID NO: 33;
Seq′Forward and Seq′Reverse are complementary to each other;
X′ is null or a spacer sequence between Seq′Forward and Seq′Reverse, and the spacer sequence is not complementary to Seq′Forward or Seq′Reverse;
∥ indicates formation of hydrogen bonds between Seq′Forward and Seq′Reverse.

2. A construct expressing the dsRNA according to claim 1.

3. A host cell comprising the dsRNA according to claim 1.

4. A preparation for pest control, comprising: a safe and effective amount of the dsRNA of claim 1 and an agriculturally acceptable carrier.

5. The construct according to claim 2, wherein the construct comprises the following structure:


Seq′forward-X′-Seq′reverse 

wherein
Seq′Forward or Seq′Reverse is a polynucleotide comprising a sequence of at least 21 consecutive nucleotides of the nucleotide sequence of SEQ ID NO: 33;
Seq′Forward and Seq′Reverse are complimentary to each other;
X′ is a spacer sequence between Seq′Forward and Seq′Reverse, and the spacer sequence is not complementary to Seq′Forward or Seq′Reverse;
∥ indicates formation of hydrogen bonds between Seq′Forward and Seq′Reverse.

6. The dsRNA according to claim 1, wherein the dsRNA inhibits growth of corn borer.